intrevivo reduces the amount of the virus in hepatitis c infection . incivo is used to treat adults with chronic hepatitis c in patients who are 65 years of age and older . it is used in combination with peginterferon alfa , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the ns3 , 4a protein inhibitor stops hepatitis c virus from multiplying and infecting other cells . it also reduces the effect of peginerferon aluminiuma and ribavir . incov is used for the treatment of adults with a confirmed diagnosis of chronic hepatitis
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been prescribed peginterferon alfa or ribavirin by your doctor . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you take any of these medicines : - if you know that you may be at increased risk of experiencing severe side effects 56 if you also take the medicine alfuzosin ( see section " warnings and symptoms "). - if your doctor has told you that you have an enlarged prostate . - if any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you . the recommended dose regimen is 3 mg twice a day ( 6 mg twice daily ) taken in the morning and evening , followed by 2 mg twice weekly ( 8 mg twice every day ). your doctor may prescribe incivo for you to treat both hepatitis c virus infection and human immunodeficiency virus infection in the evening and evening . your dose will be calculated according to your body weight . your recommended dose is one tablet twice a week ( 6 capsules ) taken
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may be severe and may last for weeks . other symptoms of the rash : a severe skin reaction tell your doctor immediately if you develop a skin rash . your doctor may decide to treat your rash with other treatments . other signs of a rash : fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash , peeling skin , fever , flu - like symptoms , painful skin blisters , bl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbulta contains the active substance daclizumab beta , a monoclonal antibody . what zinborryta looks like and contents of the pack zinbinbryt is a type of protein that is present in the body . it is a white to off - white protein . zinbolta is used in adults with multiple sclerosis ( ms ) to start therapy . it can be used as two ms treatment or as two treatments at once . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking zinryta . liver problems talk to you doctor , pharmacacist or pharmacist before taking this medicine if you : have liver problems . your doctor may need to adjust your dose of zinibryta if you are taking any other autoimmune disorders . you are not sure . you may be taking any of these medicines : herbal supplements . you should not take any
your doctor will decide how much zinbryta you need and how often you need to use this medicine . the recommended dose of zinburyta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the usual dose of your first dose of the first dose is one 40 mg tablet once a week . your dose may be increased depending on the results of this blood test . your next dose may need to be adjusted . your first treatment will be a blood sample taken before you start injecting yourself zinba will be injected under the skin in the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affects up to 1 in 100 people ): severe inflammation of the liver may lead to death . tell your liver
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe / pen label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the zinbryta pre - filled syringe in original package in order to protect from light . if you are using a new syringe/ pen , do not store it in a fridge . zin bryta syringes / pens may be stored for a maximum of 30 days in the
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml solution for injection : each pre- filled pen contains 150mg of dlizumb beta . 1ml solution for infusion : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) ( see section 2 ' zin bryta contain sodium '). what zinbaryta looks like and contents of the pack zinbenta is a clear to slightly yellow , colourless solution for injecting
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver into the eyes and brain . this defect causes liver damage and neurological disorders . wilzin works by attaching to copper in the intestine and its further accumulation in the body . wilston ' s diseases is not a cure for any of the following conditions . your doctor will discuss with you the benefits of this treatment with you .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . warnings and precautions talk to your doctor or pharmacist before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents , penICillamine , until your symptoms improve . your doctor will closely supervise the treatment . monitoring of blood and urine will be performed during treatment and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are listed below . the recommended dose is 25 mg / 50 mg twice a day . your doctor will tell you how many capsules to take . the dose will depend on your condition and your response to the medicine . the usual dose is 1 capsule of wilzin 50 mg per day . the daily dose is 2 capsules of wilzan 25 mg per morning . the doctor will instruct you how to take the dose . the maximum dose is 5 capsules of the medicine twice a morning . your dose
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) frequency not known : frequency cannot been estimated from available data very common : may affect more than one in 10 people uncommon : may affects up to 1 in 10
keep out of the reach and sight of children . do not store above 25 . do this after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule also contains 25mg of zinc , equivalent to 167 . 84 mg of the zinc acetate dietrate . the other ingredients are magnesium stearate . the capsule shell contains gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e110 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , printed with ' wilzin 50 mg ' on
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other ingredient is emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretraviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the amount
do not take biktarvy : if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these : - any of your medicines containing rifampicin ( used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) ( a herbal remedy used to help prevent depression and anxiety ) warnings and precautions talk to your doctor before taking bikarvy : - if you have liver problems .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted . your daily dose should be taken in combination with aluminium and magnesium hydroxide mineral supplements . your diet should be adjusted to include vitamins , magnesium and iron in the diet . see section 2 " important information about these medicines and biktarvy " for further information . if you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , which is needed to fight infections . there are no obvious symptoms of autoimmune disorders . when a person is infected with hiv , the immune system attacks the body tissue . medicines like biktarvy can cause autoimmune
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir tablet contains bic tegravira sodium equivalent to 50 mg bicchegravirin , 200 mg emtritabine , tenofovel ( as mesilate ) and ten ofovir aluminiumafenate fumarate equivalent to 25 mg tenofvir alufenamide the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate .
novondorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin ( a type of sugar ) to control your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your body . the insulin that your body produces does not work as well as it should . novonorm helps control the level of sugar in the blood when you have type 2abetes . treatment is usually started with diet and exercise and weight reduction . your blood glucose may be increased when you start to take novonor on its own or
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . your doctor will check the acid level in your blood regularly to prevent diabetic ketoacidosis . if your doctor has told you that you have a severe liver disease . if any of these apply to you , tell your doctor . if the doctor has given you gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you suffer from liver problems . novonors should not be used if you know that you suffer moderate liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . you may take no vonorm with food or between 30 and 40 mg once daily for up to 4 weeks . you should take no more than 30 mg once every day for up until 16 weeks . your doctor may want to increase your dose to control your blood sugar . if you take more novonor than you should if you accidentally take too
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , hypoglycemic reactions are generally mild / moderate . however , hypocemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect up
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), 1 mg tablet ( e132 ), iron oxide red ( e 172 ) and 2 mg tablet . what novonor looks like and contents of the pack novonorg tablets are white to off - white , round , flat , embossed with
pumarix is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemic fluids are similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
pumarix should not be given if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( see section 4 ). these ingredients are : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarix may occur . this vaccine should not give you 33
pumarix is for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to those in adults 18 years of age and older who are not able to have a vaccine . pumix is used in children aged 3 - 9 years and adolescents aged 10 - 17 years . how pumarx is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure and shock . doctors are aware of this possibility and are emergency treatment available . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection was fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after preparation of the vaccine , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 30 . do away with the suspension and allow the time to prepare it . do throw away any medicines via
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which is a type of protein that is present in the blood in the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants are included in the vaccine . the ingredients are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate ,
what somakit t is somakiton t is a radiopharmaceutical product containing a substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . what somakt t is used for somakits t is given to you in a medical imaging procedure called positron emission tomography ( pemphigus ). it is given by injection into a vein or into the body areas . it is used as a medical interpretation procedure ( positronission tomography ) for the treatment of a certain type of pet . during this medical procedure , images will be taken to monitor the
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had allergic reaction to any ingredient listed in the section 4 of this leaflet . warnings and precautions talk to your doctor or pharmacist before taking somaknittoc if : you have kidney or liver problems you have renal or hepatic disease you are under 18 years of age . you are suffering from dehydration . your doctor will discuss this with you during the examination . 28 you have or have had others medical conditions that affect the way your body works ( e . g
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions and will keep your informed of any changes . 29 the nuclear medicine doctor supervising the procedure will decide the quantity of somakttoc to be administered . the usual dose is 100 to 200 megabecquerel per kilogram of body weight . the administration of somackittoc should be supervised by a nuclear medicine physician who is experienced in the use of nuclear medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakit : allergic reactions ( hypersensitivity ) have been reported with somackittoc . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the site of the injection may be exposed to low amounts of ionising radiation ( for example , for cancer or hereditary abnormalities ). reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be performed before administration of somakittoc . the storage details are as follows : - immediate use : - after preparation , the product should be used immediately . - after dilution , storage at room temperature ( up to 4c 25c ) does not require any special storage conditions . - do not use somaknittoc if you notice any visible
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakt t looks like and contents of the pack somakiton t is presented as a kit for radiopharmaceutical preparation . it is supplied as a glass vial with black flip - off cap . it
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor acts by blocking the activity of hormone receptor - positive advanced breast cancer ( her2 ) in postmenopausal women , who are treated with non - steroidal aromatase inhibitors ( aids ) to keep the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroid oedema ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours ) in the stomach , bowels , lung or
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afinit if you : are allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings , precautions and precautions you should tell your doctor before taking the first dose of afininitor : if you have any problems with your liver . if you know that you have or have had any disease affecting your liver , your doctor may prescribe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor per day . if you have liver problems , your doctor may prescribe a lower dose of afginitor . the usual starting dose is 5 mg . your doctor will gradually increase your dose to 5 mg or 7 . 5 mg per day depending on certain side effects . your dose of the tablet may be increased or decreased depending on your response to treatment . if necessary , your dose may be reduced or stopped . if possible , your physician may increase your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience an allergic reaction including : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps . the following side effects have been reported with afincer : very common ( may affect more than 1 in 10 people ): increased temperature ( common ) chills ( common signs of infection ) fever , coughing , difficulty breathing , wheezing ( common sign of inflammation of the lung ( pneumonitis ) 46 common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . donot open the blister . store in the original package in order to protect from moisture . the tablets should be used immediately after opening . do this medicine if you notice any visible sign of tampering . do so and return the tablet to your pharmacist . do away with the blister and any unused tablet . do throw away any medicines via wastewater or household waste . ask your pharma
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet : each film - coated tablet contains 5 mg of of everlimus . the other ingredients are : tablet core : tablet content : tablet dimension : tablet layer : tablet surface : tablet coating : tablet coat : tablet shell : tablet base : tablet size : tablet thickness : tablet dimensions : tablet length : tablet width : tablet height : tablet diameter : tablet capacity : tablet unit : tablet volume : tablet strength : tablet - coating : hypromell
what laventair ellipta is the active substance of lavent air ellipta , is umeclidinium bromide , vilanterol . this belongs to a group of medicines called bronchodilators . what laventAir ellipta used for laventive ellipta was prescribed for the treatment of chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur every day . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . warnings and measures talk to the doctor or nurse before using lavent air ellipta if you : have asthma , have heart problems , have high blood pressure , have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ), have epilepsy , have thyroid gland problems
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . use this leaflet every day for 24 hours . do not take more than the recommended dosage . if you use more laventair ellipta than you should if you have used more lavantair elliptas than you have been told to , contact your doctor straight away . symptoms of using too much lavent air ellipta may include a sudden attack of breathlessness or wheezing . if this attack occurs , use a quick
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ) feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties immediate breathing difficulty stop using Laventair ellipta
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umecylidinia ( equivalent to 65 microgram of umelidinIUM bromate ) and 22 microgram ( 3 . 5 microgram ) vilancerol ( as trifenatate ). - the other ingredient is lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what laventAir ellipta looks like and contents of the pack lav
the active substance of tremfya is guselkumab , a monoclonal antibody . this medicine contains the active substance " il - 23 ". tremfYA is used to treat psoriasis in adults with moderate to severe " plaque psor psor " an inflammatory condition affecting the skin and nails . tremfia works to improve the condition on the skin , and the appearance of nails . it is used in adults to reduce symptoms of scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and risks talk to the doctor or nurse before using or using tremfaya if : you have ever had an infection or an infection with tuberculosis 36 you have or have ever have an infection that has spread to other parts of the body . symptoms of an infection may include infections or allergic
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 micrograms solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 to 8 weeks . you can inject tremfia yourself or with a caregiver . you should record the date of injection on the label of the pack . if you use more tremfyna than you should tremffa should be used only by a doctor or nurse . if possible , show them the pack of tremfYA . if not used immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may effect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not take this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre -- filled syringes and allow the liquid to reach room temperature ( up to 30 ) before use . do this medicine once
what tremfya contains the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is clear and colourless . tremfia is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of single - dosing syringes
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). it is used when persistent or recurrent ctph cannot be controlled by surgical treatment or exercise capacity . symptoms of the disease are the same as those of chronic thromeboembolmonary hypertension : blood pressure is too high , and the blood vessels
do not use trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if the patient has a heart problem . - have had a heart attack ( myocardial infarction ) in the last six months . - suffer from
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is usually given by a qualified healthcare professional . it is usually administered in a hospital setting . you will be given a pouches containing your treprostinil and the pump will be connected to the infusion line to prevent accidental overdose . the recommended dose is 1 to 2 . 5 mg per kg body weight ,
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in 100 people ): dizziness light - headedness fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up to1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with the vials . do reconstituted trepulmix vial : once reconstitution , it should be used within 30 minutes . for continuous subcutaneous infusion , it may be used in a single reserve ( syringe ) of undiluted trepanmix for up to 72 hours .
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial delivers 10 mg trepristinill ( as water for injections ). each 20 ml vials delivers 10mg treprosticinil ( ( as salt ). trepulesmix 2 . 5 mg : one vial of 2 . 75 ml contains 10 mg of treproprostinitil (as sodium salt ) . each 10ml vial delivering 25 mg trepistinl ( as solvent ).
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enalaparin . it works in two ways : 1 ) to prevent existing blood clots from forming and 2 ) to stop blood cl clots forming in your blood . thorinne is used to prevent blood clumps from forming in the blood of patients who have : - an acute illness - unstable angina ( problems with the heart ) - had a heart attack - blood clops in the walls of your dialysis machine - severe kidney problems
do not use thorinane : if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), you should tell your doctor immediately . if a reaction occurs to hearin , you may experience a severe drop in the number of your clotting cells
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . tell your doctor or nurse straight away if you notice any bleeding event that is unusual or unusual ( e . g . excessive bleeding , exceptional weakness , tiredness , paleness , dizziness , headache , unexplained swelling ). you should immediately stop taking your medicine and contact your doctor . if you have any of the following while taking thorinan : - a severe allergic reaction , difficulty breathing , swelling of the lips , mouth , throat or eyes , blockage of a blood vessel , or a blood clot , cramping pain , redness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have particles in them . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in each 0 . 2 ml pre -filled syringe . each 2 , 000 mg pre - infused syringe delivers 2 , 500 mg of the active ingredient enoxagarin sodium ( as directed by the european medicines agency ). the other ingredients are water for injections ( see section 2 " thorinanes contains sodium "). what thorinANE looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle
senstend contains the active substances lidocaine and prilocaine , which are local anaesthetics . senstend is used to treat lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which allows ejaculation to last longer .
do not use senstend : - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks that you have an allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ). - have a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) or anaemia ( methaemoglobinaemia ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - medicine sensitivities ( sensitivity ) may occur , especially if you have severe liver problems
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per cm2 ) of 1 ml of solution for injection in the head of your penis . after 3 weeks , the recommended effect is 24 sprays per cm² of solution . the recommended duration is 4 weeks . remove the spray container from the pump mechanism and allow the valve to relax , allowing contact with eyes , nose , mouth and ears . after removing the pump from the chamber , 1
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to 1 in 100 people ) headache local irritation of the throat or irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the place of the penis itching in the position of your erect penis a high temperature other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this time period . donot puncture or burn the container . do this to avoid tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray container contains 50 ml of lidocane and 50 micrograms of prilacaine . the solution contains 2 . 5 mg / ml of prlocaine per dose . each spray container is 6 . 5 to 20 ml . - each spraycontainer is 5 to 12 ml . what senstends looks like and contents of the pack senstEND is a clear , colourless to light yellow cutaneous spray . it is supplied
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma is advanced and cannot be removed by complete resection in adults ( treatment with surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with an autologous stem - cell transplant or a transplant . advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the active substance in opdivo , nivolumab , is
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opdivone if you : - have problems with your heart , such as a change in the rhythm or the heartbeat of your lungs ( an abnormal heart rhythm ). - have any problems with any of your lung systems ( breathing difficulties or cough ). - inflammation of the lungs ( pneumonitis or interstitial lung disease ). - diarrhoea , watery , loose or soft stools . - have or have had any symptoms of inflammation
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose of opdivone is 240 mg once daily ( 2 tablets of 480 mg ) for 4 weeks . your doctor will prescribe the strength that is right for you . your dose of ipilimumab will depend on how you respond to the treatment . for skin cancer , the recommended starting dose of either opdivor 1 mg or nivolumab is based on kilogram of your body weight . the dose will be adjusted every 4 weeks until your doctor tells you otherwise .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the infusion syringe label after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2 8 . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg nivlyumab and 240 mg /ml solution for injection contains 24 mg of the active substances . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to stroke , heart attack ,
do not take clopidogrel tad 30 if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you, or if any other reason applies to your situation , tell your doctor before taking clopridogrel tetad . warnings and precautions take special care with clopidineogrelTad : if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl tad ( 4 tablets of 75 mg ) once at the start of treatment . then
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core ; tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiog
tacforius contains the active substance tacrolimus . it is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacforius will help prevent rejection of the transplanted organ by your liver and kidneys , and will improve your condition if your body's immune system is able to accept the new transplanted organs . tacfortius will prevent rejection by your transplanted liver and heart by replacing any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , any macrolide ( antibiotic ), erythromycin , clarithromycin or josamycin . tacrolamus immediate release capsules ( e . g . tacni ) are not available . tacforia prolonged - release capsules are not recommended for use in children and adolescents under 18 years of age . tacorlimus immediate - release capsule are not suitable for use by children and adolescent . tac
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . your doctor will prescribe the same tacrolimus medicine for you . if you have had a transplant , your doctor may prescribe a different tacrolemus medicine . always take this medication exactly as described in this leaflet . check the box at the end of this leafleon for more information . if possible , take the medicine pack with you . it is important that you take the right medicine to prevent the rejection of
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you may get infections more easily while you are taking tacforius . severe effects may be possible . allergic and anaphylactic reactions ( benign and malignant tumours ) have been reported during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis ( a severely lowered number of white blood cells ) have also been reported . haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutrop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . discard 1 capsule after opening the aluminium wrapping . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg : each prolonged - release hard capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforia 1 mg : every prolonged -release hard capsule releases 1 mg of of tacrulimus (as monohydrate ) each tacforian 3 mg capsule releases 3 mg of the active substances of tacromus ( see section 2 ). tacfortius 5 mg capsules release 5 mg of a medicine of taclimus (" monohydrate ") each capsule contains 5 mg tacrolemus ( all monohydrate
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidiogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrelzentiva . warnings and precautions before taking the tablet , tell your healthcare professional if you : have a risk of bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl zentla ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do use clopidogrel zentiva in aluminium blisters after the first 30 . do this to protect from light . donot use clubidogl zentva in all aluminium blacks . do away with any unused medicine after this time period . do the following : do not take this medicine if you notice any visible
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopydogrelzentiva contain lactose ' and ' clopsidogl zentva contains hydrogenated castor oil '): tablet core : mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose
yttriga is a radioactive medicine that must not be used after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . yttrigba is stored in a refrigerator ( 2 - 8 ). it is not to be used if you are not sure . your doctor will decide if yttiga is suitable for you . your hospital will take care that you are protected from light and that it is used correctly . ytriga will be stored in tiny radiation doses . the treatment will be overseen by a doctor who is experienced in
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you must not become pregnant if you think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before you are given ytriga . - yttrada is a radioactive medicine . it is not a special type of medicine . - it is used in combination with another medicinal product ( radiopharmaceuticals ). - ytiga contains radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer carton . other medicines and
the treatment will be initiated by a doctor experienced in the treatment of medicinal products . method of administration yttriga is for radiolabelling of medicinal product for specific diseases . yttiga is intended for use by adults only . if you have been prescribed yttrada by a healthcare professional , you will be carefully monitored for signs of overdose and will receive appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . local regulations on radioactive substances are in place to protect the environment . any unused product or waste material should be disposed of in accordance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttiga is a clear , colourless to pale yellow solution in a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains the active substance cisplatin , another anti - cancer medicine , which is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not responded to prior chemotherapy . cinembra is used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide if ciamra is suitable for you if you have lung cancer at an advanced stage because your disease has responded to treatment or it remains largely unchanged after initial chemotherapy
do not use ciambra : if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciambreed ( listed in section 6 ). if you plan to stop breast - feeding during treatment with ciambra . if you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciamBra . if any of these apply to you , tell your doctor before using it . if your doctor thinks you may have problems with your kidneys , tell them before you are given ciamba . before each infusion ,
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area based on your weight and on your response to treatment . this dose may be adjusted by your doctor based on the results of your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins .
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common with a temperature of 38ºc or greater ), sweating ( common ), or infection with less white blood cells than normal ( sepsis ), which may be severe and could lead to death . chest pain ( common ) with a fast heart rate ( uncommon ). pain , redness , swelling or sores in your mouth ( very common ). allergic reaction ( common ): skin rash ( common ). burning or prickling sensation ( uncommon ) or fever ( uncommon ), which can be severe .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do away with the reconstituted solution . the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 7 , 8 , 15 and 25 .
what ciambra contains the active substance is pemetrexed . each vial of ciamra 100 mg contains 100 mg of pemetreed ( as pemetreoned disodium hemipentahydrate ). each vials of cembra 500 mg contains 500 mg of the active ingredient pemetereed (as pemetretrexed dis sodium hemipontahydrated ). after reconstitution , the solution contains 25 mg / ml of pemphigus . further dilution by a healthcare professional is required prior to administration . the other ingredients are mannitol ( e421 ), hydro
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam can help to control certain infections in your blood . immunogams may reduce the increased levels of human hepatitis b immunoglubulins and immunoglofulin g ( ig ) in blood plasma of screened adults . immunoglogam is used to treat hepatitis b virus in haemodialysed patients . vaccination is given by a hepatitis birus carrier . this enables an immune response and the development of measurable hepatitis b antibodies . vaccination and continuous prevention are also available for individuals who are infected by hepatitis b .
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products . - if your child has an iga deficiency . - an allergic response to iga containing products . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunogloglobulin may cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions may also be severe ( including nausea and arthralgia ). - if the child has joint pain or low blood pressure , or moderate low back pain . antibodies
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in accordance with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 micrograms per kg body weight given every 24 hours for 72 days . the recommended recommended dose is hepatitis b in haemodialysed patients of 500 microg / kg bodyweight given every 2 weeks . seroconversion is recommended . vaccination against patients with hepatitis b will be initiated by a hepatitis birus carrier .
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects have occurred during clinical trials with immunogaman . the injection site is usually a muscle . common ( affect 1 to 1 users of 1 ,
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . donot use immunOGam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogaman 1 mg / ml solution for injection contains 5 mg of human plasma protein ( antigen ) 96 % ( as polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . it comes in a pack of 1 vial and is supplied in a carton .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis . remicades is used in adults , adolescents and children aged 6 years and older . crohn
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these active substances if you have tuberculosis ( tb ) if your doctor has told you that you have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take more remicad than you should if you accidentally take too many tablets of remiccade , contact your doctor or pharmacist immediately . if possible , show them the
the usual dose for adults is : rheumatoid arthritis : 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : 5 mg for each kg of the body weight , taken orally . how remicade is given remicine will be given to you by your doctor or nurse . it is given as an infusion ( drip ) over 2 hours into one of your veins , usually in your arm . the third treatment will be administered by your healthcare professional
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious side effects and require treatment . if you notice any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction ( swelling of your face , lips , mouth or throat , difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles ). these reactions are rare but could be life threatening . an allergic allergic reaction may occur in more than 2 in 10 people . - allergic side effects in
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . remicad can be stored at room temperature ( up to 25 ) for up to one month . after reconstitution , remicada can be used for up - to - date periods of up to 3 months ( when stored at 2 8 ) or for up
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixamab . after preparation each vials contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicada is supplied in packs containing 1 , 2 , 3 , 4 or 5 vials
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson '. in parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan increases the amount of dopamine that is produced in the cells and helps to maintain a balance of movement .
do not take rasagiline mylan - if you are allergic to rasagailine or any of the other ingredients of this medicine ( listed in section 6 ). - if severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it is also a strong pain killer . it may affect the way some other medicines work . rasgiline melan treatment may be interrupted or stopped if you have received treatment with mao inhibitors or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you can take rascagilide mylan with or without food . if you take more rasaga mylan than you should if you accidentally take too many tablets , contact your doctor immediately . take the rasvagiline melan carton with you so that your doctor knows what you have taken . if possible show the doctor the pack of ras
like all medicines , this medicine can cause side effects , although not everybody gets them . the majority of side effects have been seen with the use of rasagiline mylan or with placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite ,
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasageiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggiline Mylan looks like and contents of the pack rasagleiline tablets are 11 . 5 mm x 6 mm , white to off - white , biconvex tablets debossed with " r " on one side and "
do not use hulio : if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection , such as tuberculosis . if you experience symptoms of infections such as fever , wounds , feeling tired , dental problems . if your child has moderate or severe heart failure . if any of these apply to you , tell your doctor . allergic reaction : allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild to moderate and usually disappear within a few days . infections : if
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years old weighing 10 kg or more the usual dose is 30 mg once a day . hulio is available as 20 mg once daily . children and adolescent from 2 - 17 years of age weighing 30 kg or less the usual dosage is 30mg once a daily . hula is available in two strengths : 40 mg once weekly . enthesitis - related arthritis in adults from 6 to 17 year
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor straight away if you notice any of the following serious side effects ( see section 4 , " warnings and precautions "): after the last hulio injection , you may experience allergic reaction ( e . g . heart failure ), severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection include fever , feeling sick , wounds , dental problems ,
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hullio looks like and contents of the pack hulios 40 mg is a sterile solution for injection containing 40 mg of adalimimumab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and has a rubber stopper . hulIO is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 sterilile
the active substance in yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ) which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma ( skin allergy ) is severe or you experience intense inflammation in your nose . - if using other nsaids ( such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used in combination with topical steroids ( cortisone ) which may increase the risk of unwanted side effects . - bleeding problems ( such a condition as haemophilia ) in the past . -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye ( s ) once a day . the recommended daily dose is 2 drops in the treated eye (s ) once daily . the drops should be used the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb and fingers , between the head and eyelid .
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
duzveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate or irregular heartbeat . you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for single use only . you should swallow the tablet whole with a drink of water . do not crush or chew the tablet . you can take this tablet with or without food . dzuveo must be taken with strong painkillers such as sufentanil 30 mg twice a day . the sublingual tablet must be swallowed whole with the disposable single -dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve in the tongue
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , especially slow and shallow breathing . if you get any of these side effects seek medical advice immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy , increased
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do discard any medicines that are not used immediately . do throw away medicines you no longer use . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of suffentenil ( as citrate ). - the other ingredients are mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid , magnesium stearate . what dzuvo looks like and contents of the pack dzuvello is a white to off - white , round oval tablet with " nvr " on one side and " 3 " on the other side . it is supplied in a single - dose
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . it also works to treat sensitive prostate cancer which has spread outside the body to other organs and cannot receive surgical treatment . it reduces the amount of testosterone in the blood . it can also help to prevent androgen ( a hormone that is involved in the growth and spread of prostate cancer ). erleada also blocks the action of androgens , which are involved in controlling the growth of the cancer . by blocking the action , apal
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if if you think you may be pregnant or are planning to become pregnant ( see pregnancy , contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine may cause seizures . tell your doctor if you have taken any medicines that may increase the risk of blood clots ( e . g . warfarin or acenocoumarol ). tell your physician if you suffer from any heart or blood vessel conditions , such as heart rhythm
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . take this leaflet with food . this medicine should be taken by mouth . if you take more erleade than you should if you accidentally take too many tablets , contact your doctor immediately . other medicines and erlead tell your doctor if you have taken more tablets than you were told to . if possible , take your tablets with food and drink .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( see section 2 ). serious side effects tell your doctor straight away if you notice any of these serious side effect . fits ( seizure ) uncommon
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apaluamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - film coat : iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide . what erlead looks like and contents of the pack er
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to carry out scan ( a pet scan ) in adults who have previously had treatment for prostate cancer . it can be used in combination with other tests to determine prostate specific antigen ( psa ), which are used to detect the cancer . an axumin pet scan is performed to help determine whether the cancer has spread to the prostate . the scan will be done under the supervision of a doctor who is experienced in the use of the diagnostic . your doctor will decide on the best time for the scan . your nuclear medicine
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . before you are given axumin , you will have a day to prepare the axumin scan . this will take about 4 hours . during the scan , you may take your usual medicines and continue to take them for the latest 60 minutes after the axulumin injection . urination will be checked
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the quantity to be administered will depend on the quantity being used . a single dose of 370 megabecquerel will be given to your child . the amount to be given will depend upon the quantity and type of
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were observed : very common ( affects more than 1 user in 100 ) the effects of the medicine were mild . uncommon ( affects 1 to 100 users in 1 , 000 ) the side effects of axumin were mild and uncommon ( affecting less than 1 users in 100 , 000 ). however , pain , rash , altered taste in the mouth and altered sense of smell were reported . the safety of this radiopharmaceutical has been demonstrated by using low amounts of ionising radiation to lower the risk of cancer and hereditary
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label and carton after exp .
what axumin contains the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as as as 16000 mg ). axumin 3200 mg : one vial delivers 3200mg of fluiclovin ( as 16 000 mg ). the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin is sodium "), multidose . 1 vial of 10 ml contains 1600mg of 16000mg of axumin . 3200 micrograms : one ml contains multidoses
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . if the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some people : if you develop too much acidity in your blood ( hyperchloraemic acidosis ). if this happens to you , tell your doctor . warnings and risks talk to the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . use in both eye and eyes : 1 drop in each eye . use azopt in both of your eyes once a day for 1 week , 2 weeks and 3 weeks . remove the azopt bottle from the bottle and wash your hands . remove from the cap . remove it from the pouch and put the cap on with a snap collar . hold the bottle tightly with both hands . tilt the cap back . pull down the back of your eyelid with a clean finger until
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects ( might affect upto 1 in 100 people ) − effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brin zolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called medicines taken by mouth to treat diabetes . it works by reducing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) to treat the following diabetes types : type 1 diabetes : your body does not make enough insulin to control the level of sugar made by your body . your body can ' t use any insulin it produces . forxigo is used to treat type 1 in adults , adolescents and children who are overweight or obese . type 2 diabetes : the body does make
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor straight away : - feeling sick or being sick ( stomach pain ), excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor immediately if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is one tablet a day . your doctor may increase your dose to 10 tablets a day ( 5 mg ) if you have a liver problem . your dose of your dose will depend on your condition . your response to forxigo for type 1 diabetes is usually one tablet of 5 mg a day , but your doctor will adjust your dose if necessary . taking this medicine swallow the tablet whole with water . forxige can be taken with or without food .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are : angioedema ( rare , may affect up to 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( rare ), may affect more than 1 in every 10 people . if you have type 2 diabetes , your blood sugar level may become too low . there have been reports of 1 , 000 cases of diabetic ketoconacidosis in patients taking forxiga . these may be due
what forxiga contains the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapglifloin . the other ingredients are : tablet core : microcrystalline cellulose , lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , yellow iron oxide ( e172
mifamurtide contains the active substance mepact , which stops the growth of certain bacteria and so reduces the activity of the immune system . mepat is used to treat osteosarcoma ( bone cancer ) in adults aged between 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able to stop cancer cells from growing . it helps to slow down the rate at which cancer is coming back .
do not take mepact : if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you have taken medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) ( nsaids ). if your heart or blood vessels are damaged . if you develop blood clots ( thrombosis ). if bleeding ( haemorrhage ). if inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor . some patients who have
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide per kilogram body weight , taken once a day for 12 hours . your doctor will decide how long you should take mepacts . your dose will be adjusted by your doctor over 24 hours . you will need to take your mepactor treatments at different times during your chemotherapy schedule . your chemotherapy will be repeated every 36 hours . duration of treatment mep
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepacts ( transient ) paracetamol . if you experience fever during treatment with mepACT , tell your doctor immediately . stomach problems ( nausea and vomiting ) and loss of appetite have been seen in patients who received chemotherapy . tell your physician immediately if you have continuing fever and chills . children and adolescents 8 years of age and older mepaction may cause an infection , rash , or any problems breathing or wheezing . tell the doctor immediately if any stomach problems
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the outer carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer cartonet in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 25 ) for up to 6 hours . do this medicine if you notice any visible sign of deterioration .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mufamurtime . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine , 2 - dioleoyls - sn -glycero- 3 - phosphate - l - serine monosodium salt ( see section 2 " mepacts contains sodium "). what mepactor looks like and contents
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness associated with rosacea ( redness of the face ). rosica is caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , thus reducing the excess blood flow and redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : - if the medicine is injected under the skin . - if your doctor has told you that you may be taking certain medicines for depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracycl
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin on the face . this medicine is applied by a gentle hand or foot . it is applied on the surface of your body . it may be applied to your eyes , mouth , nose or vagina . if you have any further questions on the use of mirvasoa , ask your doctor , pharmacist or nurse . how much mirvasoe mirvasos is applied onto the face once a day . the treatment is usually started with a small amount of gel ( a pe
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may cause worsening of rosacea ) the treatment should be stopped immediately and symptoms should be observed within 2 hours . contact allergy : allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvaso stop using mirvasoa and contact your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the tube and pumps after first opening . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparhydroxy benzoate "), propylene Glycol . what mirvasoa looks like and contents of the pack mirvas
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a target in the immune system ) which is needed to defend the body from infection and cancer . bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the veg f protein is found on blood vessels that carry blood nutrients and oxygen . be vacizumsab stops tumour growth and allows blood vessels to expand , thus increasing the nutrients
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . mvasiar may increase the risk of developing holes in the gut wall ( inflammation inside the abdomen ), such as diverticulitis , stomach ulcers , colitis or chemotherapy . mvai may increase your
dose and administration the dose of mvasi you will receive will depend on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , depending on your general condition and on the size of your tumour growing . the recommended dose of each mvasion vial is one vial of mvai every 2 or 3 weeks . your doctor will decide how many infusions you will need and how long you will be treated . your dose will depend upon how you respond to treatment with this medicine . your treatment with mvasio will
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : the side effects are usually mild to moderate and usually disappear after a few days of chemotherapy . tell your doctor straight away if you notice any of these side effects while you are being treated with mvai : allergic reactions . signs of an allergic reaction may include difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include : severe side effects ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outercarton in order to protect from light . infusion solutions may be stored for up to 24 hours at 2 to 8 , when stored in a sterile environment . after dilution in a steril environment , the product may be used immediately . if not used immediately , in - use storage times
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumb in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active ingredient bevocizumumab in 1. 4 ml . each 16 ml vials contains 400 mg of of bevagacizumaab in 16 . 75 ml of water . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack m
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults who are not able to take other medicines . it works by : - preventing refractory mantle cell cancer ( mcl ) from multiplying in your own white blood cells ( autologous anti - cd19 - transduced cd3 + cells ). mantle cell lemphoma is a cancer that affects the immune system ( the body ' s natural defences ) and affects b - lymphocytes . mantle cell lmphoma b - lmphocytes multiply in an uncontrolled way and infect other lymph tissue ( e . g . bone marrow
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - have ever had problems with the number of white blood cells in your blood ( lymphodepleting chemotherapy , see section 3 ). - have a problem with white blood cell count ( autologous use ). - are having tests or checks of your lungs , heart , kidney or blood pressure . - have any signs of infection or inflammation of your cancer ( graft -
tecartus is made from your own white blood cells . your cells will be collected by a specialised healthcare professional . your cell will be given to you by a catheter placed in your vein ( a procedure call leukapheresis ). your white blood will be taken from your blood by a doctor or nurse . the blood will then be given by a drip into your vein over a period of 3 to 6 hours . the number of your whiteblood cells will then slowly decrease over a total of 2 to 3 hours . medicines given before tecartus treatment ( lymphodepleting chemotherapy ) the modified white blood cell will
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention . the following serious side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness may be associated with confusion , memory loss , disturbances
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . infusion bag : store in the original package in order to protect from light . liquid nitrogen : the recommended dose is 150 mg per vial . this medicine contains genetically modified human blood cells and is essentially free of human - derived material . the product is stable for 36 hours at 2 - 8 . do throw away any medicines via wastewater or household waste
what tecartus contains the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti - dcp19 car t cells equivalent to 68 x 2 cd3 cells per ml . the other ingredients are : 106 anti - ccp3 + sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartucus is a clear , colourless to pale yellow solution for infusion . it is supplied in an infusion bag made of a metal cassette
januvia contains the active substance sitagliptin which belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which help to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar because your type 2abetes is getting worse . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas or glitaz
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi : - you have had blistering of the skin ( bullous pemphigoid ). januvin may cause a disease of the pancreatreas called pancreatitis ( gallstones ). - you drink alcohol excessively ( over - consumption of alcohol ) and have very high levels of triglycerides (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may reduce your dose to one 25 mg film film - coating tablet 50 mg once daily . your doctor will tell you how many tablets to take . you should take this tablet once daily , with or without food . your dose may be adjusted by your doctor . if necessary , your dose of this medicine may be increased by taking certain other medicines to lower blood sugar . your blood sugar will
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting ( these may be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop taking
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide . what januves looks like and contents of
xultophy will help to control the level of blood glucose in your blood . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin to control its level of the insulin that is causing blood sugar . your doctor has prescribed insulin degludec ( a long - acting basal insulin ) to help control your blood sugar levels . liraglutide ( a type of glp - 1 ) is another type of insulin . insulin degluudec is a long- acting basal insulcer . it helps to control yourblood sugar levels by helping your body make
do not take xultophy : if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if you have a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced to a minimum of one tablet once a day . your doctor will monitor your blood sugar levels regularly while you are taking xulture . if you suffer from type 1 diabetes mellitus or ' ketoacidosis ', your doctor may reduce your bloodugar levels while you take xulin
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for as long as your prescribed dose . you must take it at least 8 hours before or 8 hours after food . you may need a break from the meal . if necessary , you may take xulophy with or without food . xultose is supplied in a pre
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur . if you have low blood glucose , your blood glucose level may be too low ( hypoglycasemia ). see section 2 for more information . in this section , serious allergic reaction ( anaphylactic reaction ) ( frequency not known ). if you experience a serious allergic reactions , stop taking xult
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 30 . store at 2 8 for a maximum of 21 days . do away with the capsules once you have removed them from the refrigerator and have used them . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance insulin deglioudec 10 . 8 mg liraaglunide in 3ml solution . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xultphil contains sodium "). what xult
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ] and her2 [ erbb2 ]- erbb3 ]. these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working and stops them from growing . this helps to stop cancer cells from growing and dividing . this medicinal product is used to treat cancer of the lung ( non - small cell lung cancer ). giotriff is used as your first treatment in adults who have not received prior chemotherapy treatment
do not take giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has low body weight ( less than 50 kg ) - kidney problems tell your doctor if your baby has any of these serious side effects - lung inflammation ( interstitial lung disease ) - liver problems your doctor may need to perform some liver tests before you start taking this medicine - if the baby has a severe liver disease - eye problems - severe dry eyes - inflammation of the transparent layer at the back of the eye ( cornea ) - ulcers at the front
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this dose with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take the tablet pack with you
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea may be severe . if you experience severe diarrhoee , fluid loss may occur . common ( might affect up in 1 in every 10 people ) low blood potassium . worsening kidney function . if diarrhoeea occurs , contact your doctor immediately . your doctor may decide to discontinue appropriate antidiarrhoeal treatment . antidiarhoeal medicine should be taken prior to administration of giotrin
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotratif looks like and contents of the pack giotarif 20 mg film - coating tablets are white to off - white , round , biconvex ,
orkambi contains the active substance lumacaftor . ivacaftOR is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508l is a protein that is found in the cystic Fibrosis transmembrane conductance regulator ( cftr ) in the lungs . the mutation causes an abnormal cftl protein that cannot be detected by your body ' s electrical signals . lumacaptor works by helping the abnormal cctr protein to work more normally . lumaconaftor works on
do not take orkambi if you are allergic to lumacaftor , ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told by your doctor that the f508del mutation is present , orkabambi should not be used . if any of these apply to you , tell your doctor . if your doctor has told you that you have liver or kidney disease , or if the dose of orkaban is reduced . if this applies to you ( or you are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 6 mg tablet once a day for 12 weeks . your doctor will tell you how many tablets to take . the recommended orkambi tablet is one tablet once daily for 6 weeks . the tablet is usually taken with orkababab . the tablets can be taken with , or without food . the usual dose is 11 mg of orkammi once a morning . the dose may be increased to 100 mg once a 2 - day period ( see section
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below have been observed with orkambi and ivacaftor . if any of the side gets serious , stop taking orkammi and tell your doctor straight away . serious side effects that may occur with orkyambi include raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease and the worsening of liver function . other side effects include uncommon ( may affect up to 1 in 100 people ) the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellow
what orkambi contains the active substances are lumacaftor and ivacaftir . each orkaban 100 mg film - coated tablet contains either 125 mg lumacftor and 125 mg ivacftir . one orkaman 200 mg film film - coating contains either 200 mg lumasaftor or 125 mg of ivacaptor . one and a half orkapan 100 mg and 125mg film - coat contains either orkami 200 mg and 200 mg of lumacaptir and 125 μg of iviacaftor . each and a one and one half tablet contains : - ork
what lynparza is lynparanza contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the growth of mutations ( changes ) in a gene called brca ( breast cancer gene ). in some types of cancer , parp inhibitors cause death of cancer cells by stopping an enzyme that helps repair dna . what lynparlee is used for lynparzer is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it is
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . children and adolescents do not give this medicine to children under 6 years of age . other medicines and lynparz tell your doctor or pharmacist if you or your child are taking , have recently taken or might take any other medicines . your doctor may need to change your dose , or stop your treatment temporarily , if you need to stop taking it for a short time
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily depending on your response to the doses of lynarza capsules . tablets are taken with or without food . if you take more than one tablet of lynpalza per day , you may experience side effects for 8 days . take the tablet by mouth . take it at about the same time each day . if possible , take it in the evening . if necessary , take the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions ( hives ) difficulty breathing or swallowing dizziness . signs and symptoms of hypersensitivity reactions may occur . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling tired or weak
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for a maximum period of 3 days . discard any capsules that have been frozen . do this after the capsules have been opened . do away with any capsules you notice
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule with " olaparatib 50 mg " imprinted on one side and a plain , white to off - white , hard imprinted with " nvr 50 mg ". the capsule is
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is used as a nasal spray during the emergency treatment of opioid overdose in adults , adolescents and children aged 14 years and older . the use of nyxoids is not recommended in these patients . it is also used as an add - on to a nasalspray during the immediate treatment of opioids . opioid overdose is a serious , life - threatening , and sometimes fatal , event in which someone accidentally takes
do not use nyxoid : if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor or pharmacist before using this medicine . if you need emergency medical care or emergency services , please contact your doctor . an opioid overdose is a rare , but serious , event . the signs and symptoms of an opioid dose are usually mild to moderate . if this occurs , stop using this nasal spray and contact your physician 2 to 3 hours after you use a new nasal spray . if any of these apply to you ( or you
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . 1 . symptoms should be : shoulders , ears , breastbone , sternum or ear . fingernail . 2 . clear the mouth and nose of any blockages . 3 . breathe in through your mouth or nose . 4 . breathe out through your nose . 5 . breathe through your throat . 6 . breathe deeply . 7 . the most common signs of breathing is the chest moving through the chest . you may hear breathing sounds and breath on the cheek . overdose may occur if you have a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : stop taking nyxoid and seek medical help immediately : acute withdrawal symptoms may occur in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may occur with up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). - the other ingredients are trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a white to off - white , colourless solution in a pre - filled nasal spray . it is supplied in a single dose container . nyxax is available in a carton containing 2 nasal sprays in blisters
what ovaleap is ovaleep contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries . it is involved for the production of sperm and in the development of a immature egg cell . ovaleaps is used in adult women who are not ovulating and who are undergoing treatment with a medicine called " clomifene citrate " and who have not undergone assisted reproductive technology procedures ( procedures that help you to become pregnant
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you think you may have large ovaries or sacs of fluids in your ovaries . ovarian cysts . if you experience unexplained vaginal bleeding . if any of these apply to you , tell your doctor . if your doctor thinks you may be at risk of cancer in your ovarian , womb or breasts . if there is any condition that makes normal pregnancy
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use this medicinal product is for injection under the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will usually receive this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how long you should continue to use the medicine . the recommended dose of this medicine is 75 mg once a day . your dose will be increased to 150 mg once daily . you will normally receive this medication for 7 days , 14 days
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions ( e . g . skin rash and raised itchy areas of skin ) severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) this type of reaction may occur after your ovaleop injection . tell your doctor immediately if you notice any of the following serious sideeffects in women lower stomach ache , nausea and vomiting . these are the symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . do this medicine if it is accidentally frozen . if it has been frozen for more than 3 days , it must be stored at room temperature ( not above 25 ). do this if you notice that the solution is not clear or has particles in it . do away
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml solution for injection each cartridge contains 300 iiu ( 22 micrograms ) follitruin ala in 0 . 05 ml solution . ovalesap 450 iu per 0 . 75 ml cartridge : each cartridge produces 450 iiu 33 microgram ( 23 microgram ) follitonropin alpha in 0. 75 ml solution each cartridge releases 900 iiu of 66 microgram of follitroin alga in 1 . 5ml solution . the solution contains 600 iu ( 44 micro
voriconazole accord contains the active substance voriconazol . voronazole is an antifungal medicine that works by killing the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp .) and candidaemia ( a form of fun fungal illness caused by candida sp .) in non - neutropenic patients ( abnormally low white blood cells count ) to prevent candida spots infections . to reduce the amount of the fungus in these patients flucon
do not take voriconazole accord - if you are allergic to vorinazole or any of the other ingredients of this medicine ( listed in section 6 ). - if taking any other medicines , including herbal medicines . the medicines listed below may affect the way voricazole accord treatment works . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used used to relieve mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin ( used when you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your dose will be adjusted by your doctor as follows : 400 mg once daily for 12 hours . this is increased to 200 mg once every 12 hours for 24 24 hours and to 100 mg once each day . your treatment will be continued until you have recovered . if you have mild to moderate cirrh
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura , visual ac
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voronazole ( as besilate ). each voricle of voricoazole accord 50 mg film - coated tablets contains 200 mg vorbiconazose ( as mesilate ) the other ingredients of vorbicle of the 200 mg film are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lact
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older who have been exposed to ebola virus , a 2 - dose course of vaccinations , will be given to protect against ebolas virus disease caused by the zaire ebolavirus or filovirus . this vaccine contains the whole ebolairus , which will give you ebola viral disease . vaccinations are given at the same time as zabdeno vaccine , 8 weeks later . mvabeas vaccine is given at a separate visit . you should not be given mv
your child ' s doctor will supervise the vaccination course . the vaccine should not be given if your child has had a severe allergic reaction ( see section 6 . if your baby has a severe allergy reaction to an antibiotic called ' gentamicin '). the vaccine must not be administered if your newborn has had mvabea . if you have had asevere allergic reaction to any other vaccine injection . if the newborn fainted during the injection , bleeding or bruise easily . if any of the above applies to your child , tell your doctor . if he / she has a fever or an infection . if a child is taking medicines
the recommended dose of vaccine is given by a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the recommended dose is one dose of one dose ( 0 . 5 ml ) of vaccine . the second dose ( 1 . 5ml ) of zabdeno vaccine will be given 8 weeks later . if you are not sure , talk to your doctor or nurse . if the second vaccine is not recommended , talk about the first dose of the second . the first vaccine with zab deno is given 8 months after the first vaccination with zibdeno . booster vaccination with mv
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where the needle is given generalised itching . the most common side effects are : common ( will affect up in every 1 in 100 people
what mvabea contains the active substance is zaire ebolavirus 29 produced by recombinant dna technology inactivated by recombination with tai forest ebolabirus nucleoprotein marburg inactivated units ( rdna ) of 0 . 7 % and 108 micrograms / ml . the dna is made from chicken embryo embryo fibroblast cells . the other ingredients of this vaccine are trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what mvagaa looks like and contents of the pack m
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronAT may also be used to : - reduce the amount of a raised calcium level in your blood because of a tumour that has been removed from your bones . this helps to stop your bones getting weaker .
do not take bondronat : if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT : if any of these apply to you , tell your doctor before taking this medicine . warnings & precautions a side effect called osteonecrosis of the jaw ( onj ) may occur if you suffer from bone damage in the jaw . your doctor may decide to reduce your dose of bondronatin if you develop cancer or related conditions . onj
this medicine is given to you by a doctor or nurse who is experienced in the treatment of cancer . it is given as an infusion into a vein . your doctor will carry out regular blood tests while you are being given bondronat . your dose of this medicine will depend on your illness . if you have breast cancer that has spread to your bones , it will usually be given 3 - 4 weeks after your last dose . it will be given as a single dose as an injection in your vein lasting about 15 minutes . if there is a raised calcium level in your blood , it may be given 1 - 2 weeks after the last dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in up to1 in 10 , 000people ): pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . do use this product if you notice particles in the solution . do throw away any
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 mg ibandronat in a concentrate for solution for infusion . each ml contains 2mg ibandor acid . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack the concentrate for bondronate is a clear , colourless to pale yellow solution . each carton contains 1 vial or 2 vials with a bromobutyl rubber stopper .
what zeposia is zeposeia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepOSia is used for zepoesia is given to adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapshing remitting ms is caused by attacks on the nerve cells . the symptoms usually disappear within a few days or weeks . however , some problems may remain for a few months or years
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack ( angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are irregular or abnormal heartbeaters ( arrrhythmia ). if any of these apply to you , tell your doctor before taking zepo . warnings and precautions talk to your doctor or pharm
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out the dose of zeposia you need based on your heart rate and will prescribe you a ' treatment initiation pack ' which is available in your country . the initiation pack is available for patients who have not taken the other medicine . the first 4 days of treatment : one capsule of 0 . 23 mg ozanimod per day . the second 1 capsule of 4 mg capsule per day for patients not taking the other medicines . the third 3 capsule of 1 mg capsule each day for children
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may affects more than one in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ). other
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine do not take this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0. 46 mg : one capsule contains only 0 . 46 mg ozimod ( as hydration ). ozanimode ( ashydrous ) is the other ingredient . ziposia 0 , 92 mg : the active ingredient is ozimog (as hydrochlorine ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium ,
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . fluticastone fureate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinIUM bromate and vilterol belong to a class of medicines known as bronchodilators . what temybrexta is used for temybolric elliptical is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte : - asthma . temyboric elliptoe should not be used in patients with asthma . - heart problems . - high blood pressure . - liver problems . tell your doctor if you have tuberculosis ( tb ) of the lung . - any long standing or untreated infections . - an eye
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric ellipte than you should if you have used more tembric ellipta than you have been told to use , contact your doctor immediately . symptoms of temybub
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) ( copd ) the most common side effect of temybric ellipta is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat ( signs of a fungal infection ( candidiasis )
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umelidinIUM bromate , 55 microgram / umeleclidium bromeide and 22 microgram per millilitre of vilancerol ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptac contains lactose '), magnesium
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. how zininforoe works zin foro works by killing certain bacteria that cause serious infections .
do not use zinforo : if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). if any of these apply to you , tell your doctor before using zin foro . warnings and precautions talk to your doctor or pharmacist before using or using zrinforo if you : have kidney problems . have ever had seizures or convulsions .
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many tablets to take . the recommended dose is 12 600 mg twice a day ( one tablet in the morning and one tablet of 600 mg in the evening ). your doctor may increase your dose to 8 600 mg every 8 weeks if you have some infections . the dose is 8 600mg twice a week ( one tablets in the afternoon and one in the night ). your dose will be given to you by your doctor or nurse as a drip into a vein . the usual dose is 5 to 60 mg once daily . your dose may be
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects . if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . your doctor may decide to stop treatment with zinforo or to stop it altogether . medicines to slow bowel movement may affect the number of red blood cells . this may affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine . what zinFORo looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin pumpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic painful , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer : if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregaberalin psfizer . some patients taking pregaabalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may increase the occurrence
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregabialin pfeizer . you should take pregagalin pferizer once in the morning and once inthe evening . if you weigh 59 kg or more , you should continue to take preggabalin
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregaboralin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregibalin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hydroxide ( e433 ).
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical in the body that is important for movement . it is important that everyone in the family has a functioning brain , and is very important for learning and coordination . in parkinson ' s disease , the most common symptom of parkinson is sudden swings in the ability to move . people with difficulties moving may have difficulties moving . xadago can be used alone or in combination with the medicine levodopa , or other medicines used to treat parkinson '.
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is taking any of any of these : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , or tranylcypromine . these are all used in treatment of parkinson ' s disease and depression . - pethidine ( a strong pain killer ). if your dose is reduced or your child
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you how many tablets of xdago to take . if you have moderately reduced liver function , the dose should not exceed 50 mg twice a day ( see section 2 ). if you take more xadadago than you should if you accidentally take too many tablets , contact your doctor immediately . xadagon may cause raised blood pressure , anxiety , confusion
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( see section 2 ). signs include confusion , sweating , muscle rigidity , hyperthermia ( increase level of enzyme creatine kinase in your blood ), serotonin syndrome ( confusion , hypertension , muscle stiffness , hallucinations and hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa and other medicines for parkinson '. common ( may affect up
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadadago looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gloss . one tablet contains a 50 mg
zytiga is a medicine containing abiraterone acetate that is used to treat prostate cancer in adult men . it reduces the amount of testosterone in your body . zytiga also lowers testosterone in men who have prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy or who are undergoing a treatment that lowers testosterone ( androgen deprivation therapy ). it is used with another medicine , prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the full amount of fluid in their blood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your pregnant or breast - feeding is not recommended . warnings and precautions talk to your doctor or pharmacist before taking zytigiga if you have severe liver damage or prostate cancer . this medicine should not be used if you know that you are taking this medicine . if you think any of these apply to you , tell your doctor before taking this medication . tell your nuclear medicine doctor before you take ztiga if any of your nuclear medicines are used to treat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . you can take it with or without food . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack . if necessary , show the pack of tablets . if more than 2 tablets have been taken , contact the doctor . take zytigigigogog
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . your doctor may decide that the level of potassium in your blood is low . your dose of potassium may need to be adjusted . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( signs of low blood potassium or liver function test ) high blood pressure urinary tract infection ( signs include diarrhoea ) common ( might affect up to 1
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytigra looks like and contents of the pack - zytige tablets are white to off - white , round tablets , approximately 9 . 5 mm in diameter . the
fiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedile crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab works by blocking the activity of a protein called tumour necrosis factor ( tnfα ), which is involved in the inflammatory diseases and in causing the inflammation in these diseases
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you or your or his child has had a serious heart condition . allergic reaction if your , or your / his child 's child ' re allergic
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . your child ' s doctor will tell you the dose to take . the dose may be increased or decreased depending on your child '. the usual starting dose is 20 mg once a week . your children ' s physician will tell them the dose for the week . the doctor may increase or decrease the dose depending on their child ' re condition . the recommended starting dose for polyarticular juvenile idiopathic
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 ) after the last hefiya injection : allergic reaction ( e . g . heart failure ) severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre - used syringe may be used for a single period of
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear type
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . what ritemvy is used for ritemvir is used to treat adults with a ) non - hodgkin ' s lymphoma . this is an illness of the lymph tissue that affects the immune system . it affects a type a of white blood cells
do not take ritemvia : if you are allergic to rituximab , other proteins that contain ritukimab . warnings and precautions talk to your doctor or pharmacist before taking this medicine if : you are more than 6 years old . you have a severe active infection . you suffer from a weak immune system . you are suffering from severe heart failure or severe uncontrolled heart disease . you know that you have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris . warnings , precautions and precautions you should tell your doctor before taking ritemvi :
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need to have this treatment . your doctor may decide to reduce your dose or stop you using this medicine if you experience any side effects . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritmvia administration you will be given ritvia together with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . if you are being treated for non - hodgkin ' s lymphoma , you will
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills or shivering . pain at the infusion site may form blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number of
what ritemvia contains the active substance is rituximab . each ml contains 100 mg of ritukimab ( as besilate ). each ml of concentrate contains 10 mg of the active ingredient ritudimab in one ml . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemv looks like and contents of the pack ritemva is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine cheva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitafine tella is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . cape citabineteva may be
do not take capecitabine teva if you are allergic to capecitabanine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) if you ( or your partner ) are pregnant or breast - feeding if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) if your doctor
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva depends on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once daily . for children and adolescents ( aged 64 years and above ) the usual starting dose for children is 1 . 64
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you notice an increase of 4 or more bowel movements compared to your normal bowel movements . if you get any diarrhoehoea at night , vomiting , vomit , nausea and lose your appetite . stomatitis : if your doctor thinks you may have pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin - reaction : if the doctor thinks that you may be having
what capecitabine teva contains the active substance is capecitabiline . capecitavine teeva 150 mg film - coated tablets each film - coating contains 150 mg capecitaboline . the other ingredients are : capecitafine tella 500 mg film film - coat tablets each tablet contains 500 mg capecabine . tablet coating : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red
silodosin recordati belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosic recordati is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . it also reduces your symptoms . silosin Recordati is also used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your child is going to undergo eye surgery - if the child has cloudiness of the lens ( cataract surgery ) 26 - if he or she has been given silodocin recordat before , because medicine may cause a loss of muscle tone in the iris ( the coloured part of the eye ) during a surgery . your doctor will take appropriate precautions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule a day . you should take silodosein recordat for at least 8 hours . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodnosin recordatin is for oral use . swallow the capsule whole with a glass of water . you can take silosinrecordati with or without food . if your doctor advises you to take more silodosesin
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur . if you feel weak or dizzy , tell your doctor . the symptoms may include dizziness and faints . if any of the above occur , tell the doctor or pharmacist . if they occur , stop taking silodnosin recordi and seek medical advice immediately . complications following a catar
what silodosin recordati contains silodosein recordi 8 mg : the active substance is silodusin . each capsule contains 8 mg silodnosin . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosesin recordat 4 mg : each capsule contain 4 mg siliodosin . as well as mannola , magnesium starchate , magnesium laurilulfate . the printing ink contains gelatin , tartan dioxide ( i171 ), yellow iron oxide ( e172 ). what silodosiin
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section ). - tell your doctor if you have severe liver problems ( such as cholestasis or biliary obstruction ) which are problems with drainage of the bile from the liver and gall bladder . - tell the doctor if any of these apply to you . - if your doctor has told you that you have any other severe liver disease . -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed whole with some water . you can take kinzalmono with or without food . try not to crush or chew the tablet . if you take more kinzdalmono than you should if you have taken more tablets than you have been told to , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzhalmono is one 40
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( often called blood poisoning ) is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) cardiovascular events uncommon side effects : uncommon ( may affects up to one in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . once your medicine has been diluted it should be used immediately . if your kinzalmono tablet is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc unless dilution has taken place in controlled and validated a
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzaloo is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology . the active ingredient in afstylfa is lonoctocog alfa . afstila is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor v ii is involved in blood clotting and is required to clot the blood . patients with an increased tendency to bleed may also have higher levels of factor v viii in their blood . afostyla helps to protect the blood and helps to clot it .
do not use afstyla if you have had an allergic reaction to afstila or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstla . the dose and the batch number should be recorded in your treatment diary . do not use more afstlva than your doctor has recommended . allergic ( hypersensitivity ) reactions are rare in patients receiving afststylfa . symptoms of allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is one vial per day . dose and duration of treatment depending on your disease the site and the bleeding your clinical condition will be determined by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used immediately after preparation . if you have aseptic conditions , you may be given afststyl a with other medicines or
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure , dizziness ( anaphylaxis ), bleeding from factor viii medicines ( inhibitor antibodies ) ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ) patients receiving previous treatment with factor v iii ( more than 150 days of treatment ) uncommon ( may effect up to 1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a single period of up to 3 months . keep in theouter carton to protect the product from light and moisture . do use the
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg ) lonoectocog aluminium . after reconstitution with 2 . 25 mg of lonoCTocog aluminum , each vials contains 200 iu lonoactocog alpha . each 1000 iu vial provides an additional dose . after initial reconstation with 2. 5 mg of injections the solution contains 400 iu of loroctocag alfa and 1500 iu . afterinitial reconstion with 5 mg / ml of injections , each 400
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent . it is used in combination with dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidly trap dabigATran . what it is done with prax Bind is used when pradxa is not being used in patients who are undergoing emergency surgery or who need urgent procedures to stop uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 . if you have a genetic disease called hereditary fructose intolerance ( hfi ). if you drink alcohol excessively ( either every day or only from time to time ). if any of these apply to you , tell your doctor before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking the medicine . taking this medicines with dabigatran ( other medicines to prevent blood clots ) dabigATran is taken by the body to prevent formation of blood clumps
the recommended dose is 5 mg / kg body weight ( equivalent to 2 . 5 mg dabigatran ). this medicine will be given to you once a week for 5 days . you will be monitored closely while you are being given this medicine . your doctor will decide how much medicine you need . it is recommended that you receive one dose every 5 days , as this medicine is given into a vein . your dose of this medicine may be adjusted , or your treatment may be delayed depending on blood clot formation . if you miss a dose of dabigATran if you have missed a dose , it is important that you contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what praxbinding looks like and contents of the pack the solution for injection in prax bind is clear to slightly opalescent and colourless to slightly yellow solution . it is supplied in a clear glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat the following types of brain tumours : - newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then with radiotherapy phase oftreatment ( phase 3 ). - malignant glioma : - gliOBlastoma multiprongioma multicellulare or anaplastic astrocytoma . temmedac is given in combination with standard treatment .
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if any of these apply to you , tell your doctor . if you do not have any signs of a severe form of allergic response , tell the doctor straight away . warnings and precautions talk to your doctor or pharmacist before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . your doctor may give you other medicines ( anti - emetics ) to take with temomedicine to prevent nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment will be divided into two phases : treatment with radiotherapy ( con
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this can cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can lead to anaemia (' apl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do use temomedac if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozolsomide ( as mesolomides ). temomedoc 20 mg : one capsule contains 20 mg tem ozolomine ( as temolomix ). temmedac 100 mg : two capsules contain 100 mg temzolomid ( as besolomites ). temormac 140 mg : three capsules contain 140 mg temosolomile ( as desolomises ). temarmac 180 mg : four capsules contain 180 mg temizolomite ( as es
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis for sexual performance . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by helping the blood vessels in your penis to relax . this allows your penis stay hard and erect for a long period of time . this helps to maintain erectile function . ceralis is used to treat adult men who do not have
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are taking organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . these medicines may increase the amount of nitrate in your blood . - if any of these apply to you : - if : you have serious heart disease - if recently had a
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual starting dose is 5 mg once a day , but your doctor may increase your dose to 2 . 5 mg a day depending on your response to cialitas . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor . if possible
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes , frequency not known ) chest pain . these may occur more often in men taking nitrates ( frequency not unknown ). priapsim may cause a prolonged and possibly painful erection . if you are taking cialis , you may find that you do not get an erection until at least 4 hours after taking it . contact your doctor immediately if you experience sudden loss of vision ( frequency unknown ). other side effects very common ( may affect more than 1 in 10 people ) uncommon (
what cialis contains the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e 172 ), talc
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin ( a type of sugar ) to control your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your body . the insulin that your body produces does not work as well as it should . enyglID helps control the level of sugar in the blood when you have type 2abetes . treatment is usually started by diet and exercise and weight reduction . your blood glucose may be increased when you start taking enygalid on its
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your physician has told your doctor that you suffer from liver problems . if any doctor has advised you that your doctor should treat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg once a morning . your doctor may increase your dose to 4 mg once daily . your daily dose may be increased to 30 mg ( once a daily ) once a week for 16 weeks . your blood sugar may be lowered if you take enysglid more often than you should . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . however , hypoglycanemic unconsciousness may lead to coma . allergy allergy ( rare , may affect 1 in every 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect up to1 in 10 users ): stomach pain
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ), red iron oxide (< e172 ) ( see section 2 " eny glid contains sodium "). what enyGlid looks like and contents of the pack enygly
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine myla is used for azacituidine mylon is used to treat adults who have not previously received a stem cell transplantation . it is used in : - higher - risk myelodysplastic syndromes ( mds ) - chronic myelomonocytic leukaemia ( cmml ) - acute myeloid leukaemic ( aml ). aml is a group of diseases that affect the bone marrow , which results in a lack of normal blood cell production .
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacnitidine myl : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition ( such as heart attack ). - tell the doctor if you have lung disease
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet once a day . your doctor will decide how much azaccitidine myl you need to take . your dose of this medicine will depend on your height and weight . azacacitine mylan will be taken once a week for 3 weeks before starting this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it may be given under different skin areas ( sub - subcutaneous ) such
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness or shaking , jaundice ( abdominal bloating or easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure , which might be a fever , which could be a sign of an infection due to low levels of white
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine will be stored by the health professionals at the hospital or clinic . the suspension must be used within 1 hour after preparation . the azacidine myla suspension must not be mixed with water for injections . thesuspension must be stored in a refrigerator ( 2 8 ). do not freeze . the solution must be administered within 8 hours after preparation and should be used immediately . if not used immediately , in - use storage times and conditions prior to
what azacitidine mylan contains the active substance is azacinidine . one vial of powder contains 100 mg azacituidine . after reconstitution , 4 ml of water for injections is sufficient . the reconstituted suspension contains 25 mg / ml azaccitidine . the other ingredient is mannitol ( e421 ). what azacididine myl looks like and contents of the pack azacitonidine mylon is a white powder supplied in a glass vial containing 100 mg of azacacitine . pack sizes of 1 or 7 vials . not all pack sizes may be
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timololed is a beta blocker that reduces fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye due to an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness , difficulty in breathing , long - standing cough or breathing problems . - tell your doctor if the patient has severe hay fever or a slow heartbeat . - talk to your doctor before taking duotra if your baby has heart failure ( a disorder of heart rhythm ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in each eye once a day . do not use in your eyes unless your doctor tells you to . do this by using duotrav in your regular eyes . do use duotra in your normal eyes . how to use duetrav is provided in a pack . each pack contains : eye drops : 1 , 2 , 3 , 4 drop in a bottle . 1 bottle . wash your hands . remove the bottle from the bottle . hold the bottle with
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle to help protect your eyes . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) the eye eye redness . common side effect ( may effect up to 1 in every 10 people ), the eye surface inflammation or surface damage may cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging . uncommon side effects : ( may affects up to1 in 100 people ) effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substance is travoprost . each ml contains timolol 40 mg . each vial of duotrave contains 5 mg of timolols ( as timololed maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg , boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride , and hydrochlorIC acid . what duotra looks like and contents of the pack duotrev is a
nplate ' s active ingredient is romiplostim . it is a protein that helps to control low platelet counts in the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in keeping blood clots open . very low platelets can lead to bruising and serious bleeding . nplate is used to treat adults and children aged 1 year and older who have had their spleen removed or who have chronic itp previously treated with corticosteroids or immunogl
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been previously treated with other medicines containing escherichia coli ( e . coli ). warnings and precautions before taking nplate , tell your doctor if you : have a low blood platelet count ( thrombocytopenia ). your doctor may decide to reduce your dose of nplate . your platelet counts may increase if you develop blood clots . your doctor will monitor you for blood clot
children and adolescents from 1 to 17 years of age : the recommended dose of nplate is one tablet of n plate per day . nplate will be given as an injection under the skin ( subcutaneous ) over a period of 1 hour . your doctor will decide how many tablets of nome you need . how often to use nplate your doctor may decide to increase your dose of your platelet counts . your dose will be decided by your doctor . your platelets will be checked regularly by your blood doctor . the doctor will check your platelelet count regularly during treatment with nplate . your child ' s doctor will tell
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing ( blood clot ) in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indig
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romipliplostime . each vial of 125 mg contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial contains 125mg romiplustim in the deliverable amounts . each two - dose ampoule of 500 mg contains 375 mg romclostim and 250 mg romlostim each single dose ampuele of 625 mg contains 250 mg . each three - dose epilogue of 500mg romplustim
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the amount of air that gets in and around the lungs when you breathe .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovannor breez inhaler - tell your doctor if you have kidney problems - tell the doctor if your doctor has told you that you have an eye problem called narrow - angle glaucoma - tell him if you experience difficulty passing urine during treatment with tovanOR breezgeler . if you think any of these apply to you , tell your physician or pharm
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the recommended dose is one inhalation once a day . you will inhale this medicine every 24 hours at about the same time each day . the recommended starting dose is 75 inhalations once a week . you should use this medicinal product every day , at the same times each day , with or without food . how to use this product this medicine is provided as an inhaler and capsules ( in blisters ) that contain the medicine
what tovanor breezhaler contains the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopirroniumbromide and 50 microgramms glycopyronium . the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopYRronium per inhale . the other ingredients of the inhale powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovanorbor breezy inhaler 44 microlit
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms ( for example , schizophrenia ) hearing , seeing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the signs of bipolar disorder include
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvet ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuuve if you have symptoms such as wheezing , shortness of breath , lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortnessof breath . these may be signs of 25 neuroleptic malignant syndrome ( nms ), a condition which can be life - threatening and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( for 2 weeks ) and 4 . 5 mg twice daily ( for two weeks ). your doctor may adjust your dose depending on your condition . adasuve is for oral use . it should be taken by mouth . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you use more adasuva than you should if you accidentally use more tablets than you have been told to , contact your doctor immediately . if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : - any breathing symptoms , such as wheezing , cough , shortness of breath , chest tightness , which may become irritating and difficult to control . these may be signs of problems with your airways ( asthma or copd ). - light - headedness or fainting . these could be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these can be signs for a severe condition called neuroleptic
keep out of the reach and sight of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with adasuves if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine . one single - use delivers 4 . 5 mg loxagine . what adasuves looks like and contents of the pack adasuva 4 . 95 mg is a white to off - white plastic inhaler , with " lox " printed on the cap and " adasu " printed in black on the body . each inhaler is packed in a sealed foil pouch . adasuved 4 . 75 mg is available in packs containing 1 or 5 inhalers . not all pack
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent which belongs to a group of medicines called cytokines . what azaccitidine betafarm is used for azaciticidine betaparm is given to adults . azacituidine betagarm is intended for use after a stem cell transplantation in patients with higher - risk myelodysplastic syndromes ( mds ). it is also used in patients who have chronic myelomonocytic leukaemia ( cmml ) or acute myeloid leukaemic ( aml ).
do not use azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacacitrix betapham . - if the patient has decreased counts of platelets , red or white blood cells . - tell your doctor if you have kidney disease . - your doctor may want to monitor you more closely . - talk to a doctor if the person has liver disease . if you suffer from a heart
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azacita betapham you need . your dose of this medicine will depend on your height and weight . azaccitidine betabarm will be administered every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it may be given under different skin areas ( sub - subcutaneous ) such as the thigh , tummy or
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience any of the following serious side effects : drowsiness or shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever may be a sign of an infection . low levels of white blood cells may cause chest pain
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . any unused azacituidine betabarm must be disposed of in accordance with local requirements . this medicine is for single use only . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the azaccitidine betafarm suspension must be stored in the original package in order to protect from light . the suspension must not be stored above 45 . the
what azacitidine betapharm contains the active substance is azacitonidine . each vial contains 100 mg azacituidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . the other ingredient is mannitol ( e421 ). what azacididine betabarm looks like and contents of the pack azaciticidine betafarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacilitidine .
ceberdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which the body produces too much glucosylceramide . it affects the spleen , liver and bones . when eliglustate is taken with glucoslceramide , it can damage your affected organs . your doctor will test for this before you start taking this medicine . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . if any of the above apply to you , or you are not
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is taking medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - if it is taking moderate cyc3a inhibitors ( i . e . erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor before taking cerdelg . cerdelgas is only used to treat medicines that
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need to take depends on your condition and the amount you have been taking . the dose of metabolizer that you have to take is one 84 mg tablet twice daily . swallow the tablet whole with water . do not divide , crush or chew the tablet . the maximum recommended dose for adults is one and a half tablets twice a morning , with food , and one and one half tablets once a day . if you take
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the sleeve after exp . the exp date refers to the last day of that month . do this to protect from moisture . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). it reduces the amount of calcium in the blood in adult people when it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir if you are allergic ( hypersensitive ) to zoledor acid , another bisphosphonate ( the group of substances to which zoledoral acid belongs ). if this applies to you , tell your doctor before you are given zoledric acid hospirox . warnings and precautions talk to your doctor or pharmacist before you receive zoledicle acid hosp
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ) and under ' iv ' administration . this is in case of dehydration . how much zoledronic acidic hospira to take the usual dose is 4 mg . if you have a kidney problem , your doctor may lower your dose . if your kidney problem is not well controlled with zoledron acid hospir , you may be at increased risk of bone complications ( e . g . bone metastases ). how much to take your doctor will decide how much infusion of zoledic acid hospire you
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( may be determined by your doctor or by your own blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness or loosening of a tooth . these could be signs of bone damage in the jaw (
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledor acid contains 4 mg zoledoledronicacid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is supplied as a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . chemotherapy destroys nerve cells in the brain , causing people to have vomiting . this can make you feel sick ( vomit ) or make you pass out . rolapit works by stopping these nerve cells from working properly , which can cause nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking varubry : if you have depression or difficulty sleeping ( see section 2 " warnings and risks "). if you think any of this applies to you ( or you are not sure ), talk to the doctor or nurse before taking this medicine . 27 if you suffer from
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with water . you can take varuby with or without food . you may take it with or just after a meal . it may be taken with or after a snack . it is important that you take the tablet at least 2 hours before your chemotherapy cycle . if you take more varubys than you should if you have taken more tablets than you were told to , contact your doctor straight away . if possible
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately and receive appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache constipation feeling tired uncommon ( may effect up to1 in 100 people ): sore or
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . tablet coat : blue 100 mg tablet with a polyvinil chloride and
what enerzair breezhaler is enerzalder contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone furyate belongs to a class of medicines known as corticosteroids . corticostromes reduce the swelling and irritation ( inflammation ) in the smaller air
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems if you get an irregular or fast heartbeat if you suffer from thyroid gland problems if your family has diabetes or high blood sugar if you experience seizures if you develop severe kidney problems if any of these apply to you , tell your doctor .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . the medicine should be inhaled once a week . use enerzair breezhaler every day , at the same time of the day . do not inhale more than once a night . do this to help control your asthma or your symptoms . use only one inhaler once a month . use in children and adolescents use in adolescents and adolescents the recommended starting dose for children and teenagers is one inhaled inhalation twice a day ( one inhal inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other side effect include the following side effects : very commonly ( may affects more than one in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tight
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate and 63 microgram of glycopirronium bromides . each delivered dose contains 50 microgram ( 3 . 5 microlitres ) of glyopyrronia and 160 microgram( 3 . 4 microlitre ) of mometsone furuate . the delivered dose is equivalent to a delivered dose . the mouthpiece of the inhaler
clopidogrel acino pharma gmbh contains the active ingredient clopidigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thromebosis ). clopidineogrelacino pharmá gmbhs is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as athero
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of clopidineogrel agababil ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelacino pharmara gmbhl . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines :
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopridogrel apharma gmbhl per day to be taken orally with or without food . you can take clapidogl acino pi gmb h with or just after food . if you take more clopidoogrelacino pharmá gmbH than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects fewer than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 10, 000 ). not known ( frequency cannot be estimated from the available data ) very rare : may affect up to 1 in 10 people . very rare cases : may affects up to one in 10 000 . contact your doctor immediately if you experience :
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplogrel aclarica gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmá gmb h looks like and contents of the pack clopidiogrel acc
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are already taking medicines called ' antiretroviral medicines '. the active substance in delstrigo , doravirine , is a non - nucleoside reverse transcriptase inhibitor ( nnrti ). lamivudine , a nucleosiderase analogue reverse transcriptases inhibitor ( trti ) is also used . the other active substance of delstriga , tenofovir disoproxil , is also a nucleoide analogue reverse transcriptase inhibitor , ( nrti ),
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if taking any of them , tell the doctor or nurse immediately . if your doctor has told you that you are taking any or all of the following medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ), st . john ' s wort ( hypericum perforatum ), a herbal remedy used for
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for you to complete the full course of treatment for hiv infection . your doctor may increase your dose to 1 tablet a week if you take certain medicines ( e . g . doravirine ). your doctor will tell you which medicines to take . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you have any further questions on the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking delstrigo and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms ( pain or stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg of lamivudine ( equivalent to 245 mg ). the other ingredients are tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumate . a coating material containing carnauba wax e903 , hypromeellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is used every 2 weeks . if you have any further questions on the use of antidepressant medicines , ask your doctor or pharmacist .
do not use spravato - if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). - have recently had a heart attack . within 6 weeks of starting treatment , a temporary increase in blood pressure can occur . serious complications in these conditions can occur and spravo must be stopped . tell your doctor before you are given this medicine if you have a heart problem such as poor blood flow to the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravatos nasal spray is for single use only . the nasal spray device is for use in children and adolescents . the recommended dose is 1 spray , 2 or 3 nasal spray devices . one nasal spray handset is for each child . use in adults and adolescents ( aged 4 years and above ) the recommended starting dose is 4 sprays , 2 sprays and 3 nasal pump devices . use within 4 weeks of the first dose of spravata . use at least 2
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to noise in the mouth area spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious in the eyes or ears feeling like your sense of touch are deceived or mimicked irritable panic attacks change in perception 37
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available in a single - use nasal spray unit . spreamer is available as packs containing 1 , 2 , 3 or 6 nasal spray devices
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . it can be caused by a change ( mutation ) in a gene responsible for the growth of melanoma . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor before using zelberaf . allergic reactions if allergic reactions occur while you are being treated with zelbearingaf , tell the doctor immediately . if you have any symptoms of an allergic reaction , such as swelling ofthe face , lip or tongue ), difficulty breathing or rash and / or f
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for up to 8 weeks . your doctor may increase your dose to 4 mg twice a day if you experience side effects . your treatment with zelboraf may be stopped if you have vomiting . take zelbaf once a morning . take the tablet with food . it is best to take the tablets at the same time each day . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you take more zel
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelbaf and tell your doctor immediately if you notice any of the following : radiation treatment tell your nuclear medicine doctor immediately : if you get any of these symptoms , as they may be signs of radiation affecting the skin , esophagus , bladder , liver , rectum , and lungs . tell your radiologist immediately if your doctor has any of any of them . skin rash , blistering , peeling or discoloration of
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelb
duoplavin contains the active substance clopidogrel , which is a substance called acetylsalicylic acid ( saa ). it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherotrombotic
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you have painful and / or inflammatory conditions of muscles or joints if you suffer from a medical condition ( e . g . asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ) if your child has a medicalcondition that is currently causing bleeding such as a stomach ulcer or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how long you should continue to take your medicine . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , contact your doctor immediately . if possible , show them the pack of tablets . if a person accidentally takes too many tablet - like tablets , tell your doctor , pharmacist or
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel ( as acetylsalicylic acid (asa ) and 75 mg clopipidogel ( as hydrogen sulphate ). the other ingredients are : - tablet core : acetyl salicylic acids ( a ), mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to an active group of medicine called alpha - 2 adrenergic receptor agonists . it works by reducing pressure within the eye . simbrinz is used in the eyes of adult patients ( aged 18 years and older ) to treat eye conditions such as glaucoma , ocular hypertension and high pressure in the back of the eyes .
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( medicines used to treat diabetes or infections ) if any of these apply to you , tell your doctor before taking simbrinusza . if you have been taking diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines to treat depression or parkinson ' s disease ). if you take certain antidepressants . if any antidepressant medicines have been taken in
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza should only be used in the eyes . avoid contact with the drops in your eye or eyes . wash your hands thoroughly after using simbrine ( see section 1 , " how to use simbrinusza "). remove the cap and snap collar . hold the medicine with your fingers . tilt the bottle , pointing down . pull down the lower eyelid with a clean finger and squeeze until there is a ' pocket ' between the eyelid and the eye . the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . contact your doctor immediately if you experience extreme tiredness or dizziness . other side effects that have been reported with simbrinza in combination with other medicines called brinzolamide or brimonidine : common side effects ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of the brimonididine tartration equivalent to 1 . 3 mg of Brimonidine ). the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water ,
what filgrastim ratiopharm is filgrastaim ratisopharm contains the active substance filgrasteim . filgrasterim is a protein produced by biotechnology in the laboratory of escherichia coli . it is similar to a natural protein produced in the body called granulocyte - colony stimulating factor ( g - csf ). filgrateim works by encouraging the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgnastim allows your body to produce more white blood cells quickly . fil
do not use filgrastim ratiopharm : if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgraspim ratinopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratisopharm if you have ever had a cough , fever or difficulty breathing . this may be a sign of a pulmonary disorder . tell your doctor straight away if you get any of these side effects : sickle cell disease 57 left upper abdominal pain or pain at the tip of your shoulder ( this may indicate a spleen disorder ). your doctor
how much filgrastim ratiopharm is given the amount of filgrasteim ratisopharm you will receive will depend on your condition and on how well you respond to filgrasterim ratitopharm treatment . the recommended dose of filbrastim ratiopharm for adults undergoing chemotherapy is 0 . 5 mg / kg body weight once daily for 60 days . this will be given to you over 30 days . your treatment will usually last for 14 days . some disease types may be more severe . the usual dose of the first dose of your first dose is 1 mg /kg body weight twice daily
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will do regular blood tests before you are given filbrastim ratiopharm . neutrophils ( a type of white blood cells ) are a type in your blood . they are important in helping your body to fight infection . your blood will be tested before and during treatment . other medicines and filgrASTim ratisopharm tell
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrateim . filgraspim ratilarm 30 mg : each pre - filled syringe contains 0 . 5 ml of filgnastim in 0 . 05 ml of water . filgnaspim rilarm 48 mg : one pre -filled syringe containing 0 . 8 ml of fluid contains 48 mg of filmgrastrim in 0. 8 ml . the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , polys
what riluzole zentiva is riluxole zenta contains a substance called rilusole which belongs to a group of medicines called cytokines . rilustole works by stimulating the nervous system to produce its own hormones . what rilizole zsentiva is used for rilukole zENTiva is given to adults with amyotrophic lateral sclerosis ( mds ) or motor neurone disease ( mld ). mds causes the nerve cells responsible for sending messages to the muscles causing weakness , muscle waste and paralysis . mld is caused by the destruction of nerve cells . motor neurones
do not take riluzole zentiva if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease . if you experience increased blood levels of some enzymes of the liver called transaminases . if this applies to you , tell your doctor . if any of these apply to you ( or you are not sure ), talk to your doctor before taking rilzole zenta . warnings and precautions talk to the doctor before you take ruluzolezentiva : if you develop any liver problems . if yellowing of your skin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth at about the same time each day . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take the tablets with food . do not take a double dose to make up for a forgotten dose . if your doctor thinks that the effect of this medicine is too strong or too weak , contact your physician or nearest hospital casualty department immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check for this . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and engraved with the code ' ril ' on one side and the number 202 on the other side . riluxole zENT
emgality contains the active substance galcanezumab . it is a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which the body produces increased levels of cgrm . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines are usually mild to moderate . emgonality may reduce the frequency of migraine headache and improve your quality of life .
do not use emgality : if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases allergic reactions emg abnorm may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . you should see your doctor immediately if you experience such signs or side effects as described in section 4 . children and adolescents emgale is not recommended for children and teenagers under 18 years of age . other medicines and emgals tell your doctor or pharmacist if you or your child are taking
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . emgally is given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection after proper training . if you have been given more emgals than you should if you think you have received more emgsality than you have needed , contact your doctor . if more emmality than is needed , your doctor may give you a double dose to make up for a forgotten dose . if possible , show the doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . after first opening , the product may be stored for up to 8 days in a freezer ( 2 7 ) and away from direct heat ( up to 30 ) in the outer carton . do this medicine at any time during this period . do away with the blister and
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumb in 1 ml solution . the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is presented as a solution for injection in a clear glass syringe . the colour is clear to slightly yellow . the syringe is supplied in single - dose pen packs of 1 , 2 , 3 or a multipack of
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and clogged with blood clots . it can be given to you by your doctor or nurse , or by a doctor or a nurse , who have previously been treated with medicines prior to a stem cell transplantation . defibrobrotide works by helping the blood arteries to open and close , so that the blood clasts can be removed . if you have any further questions on the use
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if you take medicine to prevent bleeding ( e . g . heavy bleeding , if you need a blood transfusion or surgery ). if your doctor has told you that you have problems with blood circulation and you need to have a constant blood pressure . warnings and measures talk to your doctor or pharmacist before using defitilio . children and adolescents this medicine is
your doctor will decide how much defitelio you need and how long you need to take the treatment . defiteloio will be given to you by a doctor or nurse who is experienced in the use of stem cells transplantation . it will be infused into one of your veins ( known as an ' intravenous infusion ') or drip . you will be monitored during this treatment for 21 days until your symptoms improve . if you forget to take defitlio if you miss a dose , take it as soon as you remember and then take your next dose at its regular time . if it is less than 18 hours until your
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine and the mouth bleeding from under the skin coagulopathy ( disturbance in blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon (
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use defnitelio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrorotide ( as an add - on to the solvent ). each ml solution provides 80 mg of the active ingredient in defibritio . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow solution
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitis car virus from multiplying in your body . it also prevents the virus from spreading to other parts of your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklanza are : - tablets containing a medicine called epidermal growth factor receptor blocker . this helps to reduce the amount of the virus in your blood when you take them . dakinza
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital used to treat epileptic seizures rifampicin , rifabutin and rifapentine ( antibiotics used to prevent tuberculosis ) dexamethasone , a steroid used to correct allergic and inflammatory diseases . medicines called st . john ' s wort ( hypericum perfor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once a day . do not chew , crush or split the tablet . do this to avoid unpleasant taste . daklanza may be taken with some other medicines . if you take more daklatinza than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack of dklinza . if necessary , show the doctor the pack . if this happens , tell your doctor immediately .
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when daklineza in tandem with sofuosbuir and ribvirin has also been associated . very common : may affect less than 1in every 10 , 000 people
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack
proquad is a vaccine to prevent measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the measles , rubles , rubellia , varicellis viruses . the antibodies help to prevent diseases caused by these viruses . proquad is used to prevent adults from getting measles , measles , spread of mumps to rubella or chickenpox (" varicello "). the vaccine is given to infants 12 months of age and older . pro quad is used in children and adolescents (
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system ( for example , treatment with medications that weaken the immunesystem ) if your doctor has recommended low - dose corticosteroid therapy ( for asthma or replacement therapy ) if any of these apply to you , tell your doctor . if you suffer from a weakened immune system , a disease ( including aids ) that suppresses the immune response ( for instance , congen
proquad is given by injection into a muscle ( subcutaneously ) under the skin ( usually in the thigh or upper arm ). injections will be given into the muscle ( usually into the thigh area or into the upper arm area ). if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . bleeding may occur in the muscle . proquad will be injected into a blood vessel . pro quad is given as an injection into the skin . it is given to prevent bleeding into the blood . pro Quad is given into a vein . prorant is given every 9 weeks for a
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other side side effects reported with the use of proquad are : very common ( may affects more than
what proquad contains the active substances are : measles virus1 , edmonston strain 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain 4 . 30 mg rubella virus2 , strain 3 , 3 . 01 mg varicella virus3 , merck strain 3 .. 99 mg mrc . the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 and hanks ' salts ( mem , neomycin , phen
jylamvo is a substance that is absorbed by the body and is an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . it acts as an anti - inflammatory effect jylamv is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( with polyarthritic forms in the joints ) severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . it can be used alone or in combination with non - steroidal anti -inflammatory drugs ( nsaids ) or in addition to nsaid s . it may be used
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have or have ever had a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines if you experience an inflammation
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much jylamvo you need to take and how often to take it . the recommended dose is one tablet once a day . your child ' s doctor will decide how much of this medicine to give to your child . jylimvo may cause severe side effects , sometimes leading to even death . your physician will determine the dose you need and will adjust the dose of the treatment . rheumatoid arthritis and severe juvenile idiopathic arthritis if your child has severe
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching affecting your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ) bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry stools
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect the medicine from accidental spillage . after reconstitution , the product should be used within 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotreate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydroxybenzoates "), citric acids , tri , sodium citrates ,
what enurev breezhaler is this medicine contains a substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to help adults and children with breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine prevents this tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if there is an eye problem called narrow - angle glaucoma . - tell your doctor if you have difficulty passing urine . treatment with enurevo breez inhaler should be stopped immediately if you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using enurevi breezer . these may be signs of bronch
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine is for inhalation use . use within 24 hours of the last dose . the recommended starting dose is 75 inhalations once a week . you should use this medicinal product every day . how to use this leaflet this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ). the capsules should be swallowed whole with water . do not crush , chew
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing , swallowing , dizziness . allergic reaction may include swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , or if you notice any of them at all , tell your doctor immediately . some possible side effects (
what enurev breezhaler contains the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycoprroniumbromide equivalent to 50 microgram glycopyronium . the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is 44 microgram of glycopYRronium per inhale . the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezker 44 microlitre inhalation powder
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and infecting it . how riximyo works riximusimyo is used to treat adults with the following conditions : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . the immune system attacks a type in the body called a type
do not use riximyo : if you are allergic to rituximab , other proteins that are similar to ritonuximib , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using riximsyo .
your doctor will decide how much riximyo you will receive and how often you will need this treatment . your doctor will check whether you are being given this medicine and will decide if you need any side effects . riximeyo is given as a drip ( intra - venous infusion ). medicines given before each rixiemyo administration you will be given rixieyo together with other medicines ( premedication ) to reduce the risk of side effects during your treatment . for non - hodgkin ' s lymphoma , your doctor may give you rixima alone riximusyo once every 4 weeks .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient ritudimab ( 10 mg / ml ). the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 " rixamyo contains sodium "). what rixima looks like and contents of the pack rixIMyo is a clear to slightly yellowish solution for infusion . it is supplied in
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat adults with small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotan actv treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ . your blood cell counts may become too low ( see section " warnings and risks "). your doctor may need to adjust your dose of topotan actv . - if any kidney problems are serious . your doctor will tell you if you should be treated with topotcan actav . warnings and symptoms talk to a doctor or nurse before using this medicine if any
your doctor will determine the dose of topotecan actavis you will receive and will determine how much you will be given based on the disease and on results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for every square metre you weigh , for every 5 square metre that you weigh . this treatment cycle will also include a dose for cervical cancer . the normal dose for this treatment is 0 . 75 mg per sq metre of surface area , for each square metre which you weigh each day , for a total of 3 weeks .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . your doctor may need to adjust your dose . your general condition may include local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections and lung inflammation ( rare , may effect up to 1 in 1 , 000 people ): difficulty
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 ± 2 and from 2 to 8 when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) has been
what topotecan actavis contains the active substance is topotan . each vial contains 1 mg or 4 mg topotecaan ( as hydrochloride ). after reconstitution 1 ml contains 1mg topotican . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotnican actis looks like and contents of the pack topottecan activ is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and a protective sleeve . pack sizes
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivaldigmine works by blocking the enzymes that break down acetylchloroline : acetylchelinesterases and butyrylcholinescerase . by
do not take rivastigmine hexal - if you are allergic to rivastaigmine ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings and risks talk to the doctor or nurse before taking any of your medicines : - if any patient has
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may also adjust your dose depending on your weight . your physician will tell how long you should continue to take this medication . if you have not taken rivaldigminehexal for more than three days , do not take the next dose
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below are very common ( may affect more than 1 in 10 people ). feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may effect up to1 in every 100
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each rrivastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each rivanast
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer that has spread to other organs . it can be used alone or in combination with a specific anticancer medicine containing sorafenib . what cabometyx does cabometx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , it can prevent high amounts in cancer cells . cabometrix is used in adults .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety : - if your child has high blood pressure - if he / she has an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if the child has diarrhoea - if his / her child has recent significant bleeding - if they have had surgery within the last month - if their child is undergoing surgical procedures ( dental surgery
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . you should take this tablet at the same time each day . your doctor may increase your dose depending on your response to your treatment . this will help reduce the risk of serious side effects . your treatment will usually last for one month . your dose of cabometyx will be gradually increased over the course of 60 days . you will usually take cabometx for 2 - 3 consecutive days . if you take more cabomety than you should if you accidentally take
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx : you may be given other medicines to treat your side effects . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea , feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling ,
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg contains caboxantinibe . cabobometyx 40 mg : every tablet contains Cabozanthinib (s ) and Malate . each dose of 40 mg contains Caboxantineib . cabostyx 60 mg : one tablet contains cozantinnib ( sin ) and / or malate , each dose contains 60 mg cabozantsinib . the other ingredients are : tablet core
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemdesed hospir will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide if pemetreed hospiera is suitable for you if you have lung cancer at an advanced
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have had problems with your kidneys . before you receive pemetreoned hospiar , your doctor will check the amount of fluid in your blood (
the dose of pemetrexed hospira that you will receive is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area according to your weight and will determine the dose you should receive . treatment will be delayed depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetresed hospire will be
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash , burning or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at 2ºc - 8ºc . the reconstituuted solution should be used immediately . parenteral medicines : if you notice discolouration prior to administration , this medicine should be administered
what pemetrexed hospira contains the active substance is pemetre . pemetrixed hospiras 100 mg : each vial contains 100 mg of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetoxed hospiry 500 mg : one vial of 500 mg contains 500 mg ofpemetrexing ( as pyrexeddisodium hemispentahhydrate ). the recommended dose of pemoled hospira is 1 , 000 mg . the recommended dosage of petrexed is 1 mg / ml of pererexed as pet
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work by blocking a prostaglandin analogue ( timololine ). it belongs to medicines called beta - blockers . ganfort is used to lower pressure in your eye . it is used in adults whose eye is a clear , watery liquid in the back of the eye , and in children whose eye has not been opened before . gansfort is also used in children with glaucoma . g
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol or beta - blockers ( see section 6 ) - if your child has respiratory problems such as asthma or severe chronic obstructive bronchitis - if he / she has severe lung disease - if the child has wheeziness or difficulty in breathing - if they have long - standing cough - if his / her child has heart problems - if their child has low heart rate - if there is a history of heart block or heart failure warnings and precautions talk to your doctor or pharmacist before using this medicine - if any
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment use the bottle and the carton . - do not put the bottle in your neck . 5 . gently squeeze the bottle . 1 . wash your hands . - tilt your head back . 2 . pull down your eyelid , which is hidden by a small pocket . 3 . gently press down on your eye until it is completely closed . - after treatment , 4 . gently pull down the lid of your eye . 5. gently squeeze your eye with a finger . - gently squeeze back
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause some side effects when taken with ganart ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the
keep out of the reach and sight of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do use ganedfort if you notice that the solution is discoloured or contains particles , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ) timolol . each ml contains 5 mg of timolov maleate in 6 . 8 ml . - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , colourless to pale yellow eye drop . ganf is
gefitinib mylan contains the active substance gefitinib . it works by blocking a protein called epidermal growth factor receptor ( egfr ). this protein is involved in the growth and spread of cancer cells . gefinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefnitinib melan . if you have any other lung problems . some lung problems may be serious . gefinib yourlan may cause problems with your liver . talk to a doctor , nurse or pharmacist before taking this medicine . gifitin ib mylan is not recommended for use in children and adolescents under 18 years of age . other medicines and g
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you may take antacids on an empty stomach for 2 to 1 hour before or after food . gefitinib mylan can be taken with or just after food , if you have trouble swallowing the tablet . if you take any other liquids , contact your doctor . the maximum recommended dose for adults is 20 mg once a morning . if possible take gefitoninib melan at
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting parts of the body .
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefginib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide red ( e 172 ). what gefnitinib melan looks
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) which can be caused by lack of red blood blood cell transfusions . reblozey is used : to treat anaemia in adults with mds who cannot be treated with red bloodcell transfusions ( erythropoietin therapies ) in patients with beta - thalassaemia
do not take reblozyl : if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy and breast - feeding ). warnings and precautions talk to your doctor or pharmacist before taking this medicine : if your doctor has told you that you have thalassaemia ( a condition where the spleen removed ) because you have had a blood clot , or if you have been treated with hormone replacement therapy because of a previous blood clot . preventive measures are needed to prevent medicines from causing a blood clot . if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reblzyl is given as an injection under the skin . the dose depends on how much you weigh . the injections should be given in a single dose of 1 . 0 mg / kg body weight . your dose may be adjusted by your doctor depending on your blood pressure . your physician will decide the correct dose of rebluzyl for you . if you have myelodysplastic syndromes the maximum single
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in other parts of the body , with blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for a single period of up to 25 days when stored at 2 8 . do away with any unused medicinal product or waste material . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg luspaterscept . after reconstitution , each mlof solution contains 50 mg lsuspatercept ( as excipients ). the other ingredients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pcp / ph adjustment ). what rebl ozyl looks like and contents of the pack rebloxyl is a white to off - white powder . reblosyl 25 mg / 75 mg solution
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer by stopping cancer cells from growing and forming new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda . high blood pressure tell your doctor if you have any problems with your blood pressure . your doctor may prescribe you a medicine to lower your bloodpressure . fotiva may lower your dose of fotiquda if your blood hypertension
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days . this 21 day period will be followed by 7 days without capsules . this 4 - week period will also be followed with a maintenance dose of 1 mg once daily . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . severe side effects may occur during fotrevda therapy . the usual dose of the fot
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience high blood blood pressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension may be treated with a medicine to control your high bloodpressure . if you take more fot
what fotivda contains the active substance of fotivex is tivozanib . each tablet contains 890 mg of tivuzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : ( 890mg tivzanib ), mannitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( titanium dioxide , e171 ) and tartrazine aluminium lake (
stribild contains the active substances elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antitroviral medication called aucleotide reverse transcriptases inhibitor ( rtti ). stribild is given as a single tablet regimen to start the treatment of human immunodeficiency virus ( hiv
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir or tenofavir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). if you have not responded to treatment with any medicine containing tenofvir disaproxil , your kidney function may be monitored by your doctor . if you take any of these medicines : alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats )
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet taken by mouth once a day . you should take your medicine at the same time each day . your doctor may change the dose or stop the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc ) which may affect the absorption of stribild . see section 4 for further information . if you forget to
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hla - b * 5701 virus or by the other ingredients of the hl disease itself . serious side effects tell your doctor immediately :
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabINE and 245 mg tenofvir disopicroxil ( as mesilate ). each tablet contains 300 mg ten ofovirdisoproxel fumarate , equivalent to 136 mg tenorovir . the other ingredients are : tablet core : croscarmellose sodium
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zyprixa . zypitxa has not been studied in elderly patients with dementia . serious side effects have been reported
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . you should take zyxa between 5 and 20 mg once a morning . if your symptoms return but do not stop taking zypoxa do not take your zypxa tablets without talking to your doctor first . take your tablets at the same time each day . zzyprexa coated tablets can be taken with or without food . swallow the tablets whole with a glass of water . do not crush or chew them . if you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue . this may be a sign of blood clots in the veins . this side effect is uncommon ( may affect upto 1 in 100 people ) especially in the legs . symptoms include swelling , pain , and redness in the leg which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately . a combination of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . zyprexa does not require any special storage conditions . do this by referring to the package leaflets that are provided with each tablet . do you notice any change in the appearance of the tablets ? do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zyprixa tablet strengths are marked with the following symbols : - zypi 2 . 3 mg , 2 . 4 mg ,
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . prolia helps to prevent bone loss in patients with osteoporosis when treatment is first started . prolias helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen that your body makes . this helps to keep bones healthy . after the menopause , oestrogens level drops to a low level and makes bones thin and fragile . what osteopORosis is osteoporeosis is caused by
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor before using this medicine . if any of them apply to your , tell the doctor before you use prolium . if your doctor thinks you may have a skin infection , symptoms include a swollen , red area of skin ( usually in the leg ), which feels hot and tender .
what prolia is prolia contains one pre - filled syringe of 60 ml . it is given to you by your doctor or nurse , as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . your doctor will decide how much prolia you need and how often you need to receive it . your dose will be decided by your healthcare professional . your treatment will be started by a doctor or a nurse . your healthcare provider will decide if you need calcium and vitamin d supplements . how prolia works prolia can be given to adults , adolescents and children aged 6 years and
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor straight away if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . stop using prolia if you experience pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone damage in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at room temperature ( up to 25 ) for a single period of maximum three months . after the injection , it may be kept at room temperatures ( up or down ) below 25 for a maximum period of not exceeding 30 days . do this as your doctor or pharmacist has told
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine for adults and adolescents from 1 to 15 years of age . it is used to treat two diseases : hepatitis a and hepatitis b : infection with the hepatitis a virus . the liver is swollen and inflamed by the virus . it can be caused by any of the following : - the virus in an infected person . - the hepatitis b virus in faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . - you may feel sick , have a fever , aches or pains , feel very tired , dark urine , pale faececes or yellow
do not use ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using ambirx if you : have ever had hepatitis a or hepatitis b diseases . have a severe infection with a high temperature . the vaccine should be given at the same time every year . have ever
your doctor or nurse will give you ambirix as an injection into a muscle in the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . if you miss an injection , the second injection should be given between 6 and 12 months after the first . if it is more than 12 months since the first injection , you will be told to take extra doses to make up for future booster dosing . if more than two injections are given at once , it is unlikely that you will not
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( hepatitis b surface antigen ) equivalent to 20 microgram / ml . the other ingredients are human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly milky liquid . each pack
what bexsero is bex sero is a meningococcal group b vaccine . what bex Sero is used for bex serumo is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are very sensitive to the effects of the vaccine and can cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex serumo if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to postpone vaccination until you recover from haemophilia . you have any other problem that may prevent your blood from clotting properly . you are taking blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculizum
your doctor or nurse will give you bexsero at a dose of 5 micrograms . the injection will be given into a muscle ( usually in the thigh or upper arm ). the first two injections will be made at a separate injection site ( see section 2 ). the second injection will usually be given at a different injection site . the third injection will normally be given between 2 and 5 days . your doctor will decide how many injections you need . three injections will give the vaccine . your dose will be adjusted by your doctor . your second dose will usually consist of an additional injection ( booster ). the third dose will normally consist of
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness of the area of the injected area at the area where the injection is at the time of injection . if any of these side effects occur , stop using this vaccine and tell a doctor straightaway . common ( might affect
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 50 micrograms recombinant nisseria maningitidas group b noada protein 1 and 2 , 2 and 3 50micrograms reconstituted as recombinant neoisseria meingitis group b fhbp fusion protein 2 and 2 and three 50 microgna per vial . the other ingredients are : outer membrane vials ( omv ) neissia meningitsidis group c strain ( total protein ) thepora p ( e
nitisinone mdk contains the active substance nitisinONE . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children from 1 year of age . due to this disease your body cannot break down the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone helps to break down tyrosrine and the harmful substances it contains . this medicines helps to reduce the amount of tyrosin in your body . it also helps to lower the amount low tyrosines and phenylalanine ( another
do not take nitisinone mdk if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone md k may affect the eyes . during nitisinfone treatment , red eyes may occur . if you notice red eyes , tell your doctor immediately . your doctor may recommend an eye examination . if any of these apply to you , tell the doctor . eye problems due to inadequate dietary control may occur ( see section 4 ). your doctor will monitor you closely
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will determine the dose of this medicine to be taken according to the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day , with or without food . the dose may be increased to 20 capsules once a daily . in this patient population , the dose is based on body weight . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone md
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . do away with the blister if you notice it is not clear . do discard the blister after 2 weeks at a temperature not above 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitis inone mdky 2 mg : each capsule contains 2 mg nitisine . nitesinone dk 5 mg : one capsule contains 5 mg nisinone . nisinnone mdyk 10 mg : two capsules contain 10 mg nitesine . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze and nitisginone . what nitisinnone looks like and contents of the pack nitisinfone mdks capsules are 15 . 7 mm long ,
docetaxel accord contains the active substance docetaxeli . docetxel accord belongs to a group of anti - cancer medicines called taxoids . docenaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer : docetixel could be administered either alone or in combination with doxorubicin or trastuzumab or capecitabine . - for early breast cancer with or without lymph node
do not use docetaxel accord : if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) if you have a low number of white blood cells if you suffer from a severe liver disease . warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may cause fever and infections . tell your doctor immediately if you experience abdominal pain , tenderness , diarrhoea , rectal ha
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine your dose . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you will usually receive your infusion once every 3 weeks . your blood tests will be taken regularly to check your generalcondition . in particular , docetAXel accord should be used in the
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be increased when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do away with the vials after dilution . the medicine should be transferred from the infusion bag to the infusion vial immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours at 25 . infusion : the infusion solution should be used immediately . non -
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetel . 1 ml of the concentrate contains 20mg docetoxel . 4 ml of solution for injection each ml ( 0 . 5 ml concentrate contains 80 mg docelaxel ). 8 ml ( 1 . 5ml concentrate contains 160 mg docotaxel ) - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol an hydrous "), citric acid anhydrated ( see " docel accord
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . this medicinal product helps to control the actions of your brain . intuniv is used to treat impulsive , hyperactive adults . this medication is used in adults with ' attention deficit hyperactivity disorder ' ( adhd ) when current stimulant medication is not controlling adhd symptoms . the medicine is used together with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuiv is also used in children and adolescents 38 years of age and older for adhd . it
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunv if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you have ever fainted or have recently had thoughts or feelings of suicide . you may be at risk of any other psychiatric conditions ( withdrawal symptoms ). increased heart rate . high bloodpressure . if you take this medicine at any time during the day or night , consult your doctor . this is because this medicine
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased depending on your response to treatment . the starting dose is 0 . 05 mg / kg of bodyweight once daily for the first week . your daily dose will then be gradually decreased until the lowest dose is achieved . your treatment will then continue for 1 to 7 weeks . your next dose
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should take your medicine and call your doctor straight away . serious side effects tell your doctor immediately if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ) hypotension ( slow heart beat ( bradycardia ), feeling faint and loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur , stop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use this medication if you notice that the tablets are damaged or are not clear . blister pack : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg guanFacine . each extended - release dose contains 2 mg guinfacine ( see section 2 under ' intuniver contains guanfu '). each prolonged prolonged -release dose contains 3 mg guaconfacine [ see section 3 under ' what intunivers looks like and contents of the pack '). the prolonged - releases are : each prolonged release tablet releases 3 mg of guan Facine ( corresponding to 4 mg of the total daily dose of guinFacine ). the other ingredients
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida ( echinocandins ). these medicines prevent serious fungal infections by preventing the growth of fungalls . ecalta works by blocking the growth and spread of fungonous cells called fungal cell walls . ecalda is used in adults where fungalcells have incomplete or defective cell walls , which may make them fragile and
do not use ecalta : if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra : if your liver function is not well controlled . if you have liver problems , your doctor may reduce the dose of your treatment or may give you anaesthetics . your doctor will monitor your condition during and after your treatment with ecaltree . if an allergic reaction occurs , you may experience itching , wheezing ,
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 hour before breakfast . adults ( 18 years of age and older ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a week , followed by 1 . 5 mg /100 mg given three times a week depending on the patient ' s weight . ecalta is given as slow infusion ( a drip into a vein ) lasting 1 . 4 to 3 hours . the loading dose will depend on the infusion size and the patient's weight . duration of your treatment your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately after dilution . chemical and physical in - use stability has been demonstrated for 24 hours at 2 - 8 . from a microbiological point of view , the infusion solution should ideally be used within 25 hours . if not used within 48 hours , the product should be discarded .
what ecalta contains the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( human cogulation factor iii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced in the body . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi : if you are allergic to rurioctocog alfa pegol or octocog aluminium ( the other ingredients of this medicine are listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using adynov : if an anaphylactic reaction ( a severe , sudden allergic reaction ) occurs , stop using adnovi and contact your doctor immediately . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , whe
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia . adynov is used for treatment of bleeding in adults . adnovi is used as the replacement therapy for adynocid . adynaovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . dosage and bleeding the recommended dose of adynova is 40 mg once a day . your doctor may increase your dose to 50 mg once daily for 2 weeks to control bleeding . the dose of adsynovi depends on your body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur after the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is immediately available . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies ( see
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . do this medicine if it has been stored at a room temperature not above 30 for a longer period of more than 3 months ,
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu of rurlioctocag alfapegol . the solvent vial is provided with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , polys
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ). they are produced by the ovaries and are responsible for the creation of many egg sacs .
do not use this medicine if any of the following apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have : a large tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus . enlarged ovaries or cysts on your ovaries . polycystic ovarian disease ( bleeding from the vagina ). an early menopause . malformations of the sexual organs . pregnancy . fibroids of the uterus . pregnancy and breast - feeding . ovarian hyper
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you by your doctor during your first treatment cycle . your doctor will tell you how many injections you need . your dose will depend on : how much anti - müllerian hormone you are taking . how much your ovaries are producing . stimulation with gonadotropins . how often you need to have injections . the amount of medicine in your blood . your body weight . your physician will take a blood sample during the last 12 months to check how well
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are involved in infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms seek medical advice straight away . a side effect may affect up to 1 in 10 people headache nausea ( ovarianhyperstimulation sensation ) pelvic pain or discomfort ( ovarian origin tiredness ( fatigue ) uncommonly may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . if refrigerated , the solution may be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 hours at 3 to 28 , but should not exceed 25 . during the treatment any unused solution should be
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient follitrotin deltain each millilitere of solution ( corresponding to 0 . 35 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptone contains either fluticasaone furuate 92 mg or vilancerol 22 mg . each adult inhalation contains either either flitasonefuroate 184 mg or either vilansterol 22 / 22 mg or both . chronic obstructive pulmonary disease ( copd ) in adults and adolescents 12 years of age and older : the usual dose is 184 mg once a day . asthma in adults 12 years and older and adolescents weighing 184 mg and 22 kg :
do not use revinty ellipta : if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ellipta . ellipta has not been studied in patients with liver disease . it is not known whether ellipta causes side effects in patients who have moderate or severe liver disease , but the lower strength of revintchy ellipta 92 / 22 mg tablets may be harmful to patients with heart problems , high blood pressure , tuberculosis ( tb ) of the lung , or
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhalational dose ) with fluticasone furoate and 22 mg vilanterol . for severe asthma , the higher strength inhaler is one application twice a daily ( one inhale twice a morning and one inhalations twice a afternoon ) with either fluticasaone firoate and 21 mg vilterol ( for copd ). for copdi the recommended starting dose is one inh
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta may occur rarely ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you have immediate breathing problems while taking revinty ellipta your
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of fluticasaone furuate and 22 microlitre of vilancerol ( as trifenatate ). each 184 microgramsis inhalation provides 184 microliters of flilitasonefuroate , 22 micrometre of the active substance is vilansterol (as trifnatate ) . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is sodium "
atripla contains three active substances used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosiderase reverse transcriptases inhibitor ( tnrtis ), tenofovir , aucleotide reverse transcript enzyme inhibitor ( rtti ). these active substances are all given together with antiretroviral medicines . how atripla works atripola works by interfering with the normal working of an enzyme ( reverse transcriptasing ) in the virus
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects may be more common ( dizziness and drowsiness ). if you take more atripola than you should if you accidentally take too many atriblea tablets , contact your doctor immediately . if you forget to take atriplea if you miss a dose , take it as soon as you remember .
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) rare ( may affect up to 1 in 1 , 000 people ) serious side effect tell your doctor immediately if you experience any of the following serious sideeffects : lactic ache ( short
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavenirenz and 200 mg emtripitabINE and 245 mg tenofvir disopicroxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atribla contains sodium ").
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin . it is a synthetic version of the natural gonadonotrophins releasing hormone ( gnrh ). release of gonadotropins is a natural hormone that stimulates follicle stimulating hormone ( fsh ). gonadots play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells and live in the follicles . they then go back to the ovary and
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ), a gnrh analogue . - if your child has a moderate or severe kidney or liver disease . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if you develop an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions if you experience allergic reactions ( generalised , hives , urticaria
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is intended for use in women who are undergoing the treatment of assisted reproduction techniques , including in vitro fertilisation ( ivf ), ovarian stimulation ( follicle stimulating hormone ) and corifollitropin . the treatment is given on day 2 or 3 of each cycle . orgdalutran will be injected under the skin ( subcutaneously ) by a doctor or nurse . the recommended dose is 5 mg per day . the dose may be increased or decreased by up to 6 mg per
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . this is uncommon ( may affect up to 4 in 1 , 100 people ). a side reaction that may be severe is headache , nausea , malaise . this rare ( may effect up to 1 in every 10 , 000 people ) side effect is allergic reactions ( rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , solvent - free solutions . do this to protect from light . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( see section 2 ). - the ph is sodium hydroxide and acetic acids . what orgaluitran looks like and contents of the pack orgalUTran is a clear , colourless aqueous solution . the solution is clear and colourless . it is supplied in a glass vial . the vial is for subcutaneous administration . the needle is inserted into the vials . the product is
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , the cell dies . what blitzima used for blitzima can be used in adults with : a ) non - hodgkin ' s lymphoma this is an disease of the lymph tissue that affects the immune system . it affects a type a of white blood cells called b - locytes . blitzima may be
do not use blitzima : if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor or pharmacist before using blitzima if you : have ever had hepatitis b or c . have ever have hepatitis b infection . this infection can be life - threatening . have heart problems ( such as angina
how blitzima is given your doctor will decide how much blitzima you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , your doctor may reduce your dose . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your treatment will be repeated every three weeks . if your doctor determines that
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml solution . each 50 ml vials contains 500 mg of the active ingredient ritudimab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials , each containing 50 ml . pack size of 1 vial .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain . this target is found in the cells of the body and helps to reduce the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactorra reduces the damage to the cartilage and bone in the joints caused by the disease . roacticemra is used to treat moderate to severe active rheumatoid arthritis , an autoimmune disease in which previous therapies did not work well enough or
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . during and after the infusion , tell your doctor if you develop any signs of infection or infections . tell your physician immediately if you feel unwell . roactema may affect your body ' s ability to fight infections . if
the doctor or nurse will give you roactemra by a drip into a vein ( intravenous infusion ). your doctor or a nurse will decide on the dose you need . the intravenous treatment will be started by a doctor or other healthcare professional . the treatment will usually last for an hour . the recommended dose of roactlemra is 8 mg per kg body weight . the usual dose is 4 mg per kilogram body weight for the first week . the maximum recommended dose is 8 g per kg of body weight , given once a week . your doctor will decide how many weeks you need to be treated . the dose of your
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting in patients taking the medicine ( see section 3 ): stop taking roactamra and see a doctor straight away if you notice any of the following serious side effects : common ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin bl
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and the vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg / ml ). each 20 ml vinal contains 400 mg of the active substances tocilixumab , 20 mg per ml . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack
what onbrez breezhaler is onbrezer contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbrezezhalzer is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine relaxes these muscles in your lungs , making it easier for air to get in and out of
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is getting worse . warnings and precautions talk to your doctor or pharmacist before using onbrezer . - if any of these apply to you , tell your doctor before using this medicine . - you have heart problems , epilepsy , thyroid gland problems ( thyrotoxicosis ), or diabetes . during treatment with onbreez breez inhaler , tell the doctor immediately if you get tightness of the chest , coughing , wheezing or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 microgram twice a week depending on how you respond to the treatment . your inhaler will be used 24 hours after you last inhaled it . how to use onbrez breezhaler you will find an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ). the onbreez breez inhaler contains the medicine and capsules are provided in separate blisters
what onbrez breezhaler contains - each onbreez breez inhaler 150 micrograms inhaler contains 150 microlitres of indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule contains gelatin . - eachonbrez bronzhalER 300 microgramsis inhaler 300 microlitre inhaler : indacateol (as indacataterol maleates ). - printing ink : shellacose and capsule contains printing ink , gelatin . what onbrex breezeler looks like and contents of the pack onbrezy bree
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to stroke , heart attack ,
do not take clopidogrel hcs : if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrel clcs . warnings and precautions before taking the tablet , tell your healthcare professional if you : have a risk of bleeding such a medicalcondition that puts
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopipidogl ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil : tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , tal
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been treated with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). if this happens , contact your doctor immediately . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , stop using
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours . it may take up to 2 weeks for fetcroja treatment to work . your doctor will check your infection and treat any pain during the fetcroJA infusion . it is recommended that you continue to receive fetcrojade for as long as your doctor continues to prescribe it . if you are being treated for kidney problems , your doctor may decide to reduce your dose of fetcroje . if your doctor thinks that you may be having kidney problems after receiving fetcroju , your dose may
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines may slow bowel movement . other possible side effects the following side effects may be serious : common ( may affect up to 1 in 10 people ): feeling sick
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefingerocol . the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojade is a white to off - white powder for concentrate for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomATous meneningitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared from the blood of healthy adult patients . it is used when lymphoma tumour cell are growing out of control .
do not use depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions severe neurological side effects can occur with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . you should not be given any dexamethasone tablets to treat unwanted effects . your doctor will monitor your side effects closely and treat any
before starting treatment of cancer , the doctor will have placed a deposit in a lumber sac . depocyte will be given to you by a doctor or nurse . the amount of depocyte that you will be able to receive will depend on the type of cancer you have . the doctor or nurses will calculate the correct dose for you . the recommended dose is one vial of depocytes per day . the dose will be adjusted by your doctor depending on the severity of any side effects you may experience . the usual dose of depolean is one ml of solution for injection at room temperature ( up to 22 ) and one vials of 30 ml
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare cases : very rarely ( affects fewer than 1 in 10 users ). reporting of adverse events if you get any side effects talk to your doctor or pharmacist . depocyte may be administered in combination with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). do not freeze . depocytes should be used within 4 hours after preparation . do this to protect from light . do do not remove depocyte from the refrigerator . do away with this medicine if you notice severe discolouration , a changed appearance or a defective container . do discard depocyte if it is discol
what depocyte contains the active substance is cytarabine . one ml of suspension contains 10 mg cytarbine . each vial of depocyte 5 ml contains 50 mg cytabine ( as cholesterol , triolein ). the other ingredients are dioleoylphosphatidylcholine , dipalmitoylosphatidoylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless solution for injection . it is supplied in a 5 ml glass vial as a single injection . each pack contains one
what bemrist breezhaler is bemist breez inhaler contains two active substances , indacaterol and mometasone furoate . indacasterol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to an important group of medicine called corticosteroids ( steroids ). corticostromes reduce the swelling and irritation ( inflammation ) in the smaller airways , which can lead to breathing problems
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemrid breez inhaler . - if your doctor thinks you may be allergic . - tell your physician if you have heart problems , such as an irregular or fast heartbeat . - you have thyroid gland problems . - have diabetes , high blood sugar , seizures or low level of potassium in your blood . - suffer from severe liver problems . tell
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be used every day . you should use the medicine every day , at the same time of the day . do not change the dose unless your doctor tells you to . if your asthma does not improve or your symptoms get worse , your doctor may prescribe bemrid breez inhaler . how bemist breezhhaler is used bemrit breezheer is supplied as an inhaler and capsules . the medicine comes in a separate sachet
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of your tongue , the lips , face or throat ( angioedema ). other side effects other sideeffects include the following listed below : very rare ( may affects more than one in 10 , 000 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhalation of bemist breez inhaler 125 micrograms / 62 . 5 microgram contains 173 microgram indacate . the other ingredients are 150 microgram of indacatesol and 80 microgrammometason furoates . the mouthpiece of the inhaler contains 125 microg of indaceaterol and 62 . 95 microgram mometsone furuate . one inhalation ( inhalation ) of beemrist bree
the active substance of zyllt , clopidogrel , belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zylltic is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to stroke , heart attack , or death ). you have been
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions before taking zylltt , tell your doctor if any of these apply to you . if any part of you is not sure , talk to your doctor or pharmacist before taking this medicine . if : you have bleeding such a medicalcondition as internal bleeding ( such as , a stomach obcer ) you have
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended starting
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the film - coating , hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in thefilm - coating . what zyll
lamivudine teva contains the active substance lamivudrine . lamivudaine tella is used to treat long term ( chronic ) hepatitis b infection in adults . lamvudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudine tla reduces the amount of hepatitis b in your body . this results in a reduction in liver damage
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamivuine tevas , like other similar medicines , may cause serious side effects . - if your liver disease ( hepatitis c .). - if overweight . your doctor will do blood tests before you start your medication . see section 4 for more information . warnings and risks talk to your doctor before taking lamivuxine tella . your hepatitis may get worse while you are taking lamvudine . if you have any problems , your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor will prescribe the best dose for you . lamivudine teva is used to treat your hepatitis b infection . it is important that you take the tablets exactly as described in this leaflet . you can take lamivu teva with or without food . it does not matter whether you take them with or with food . if you take more lamivudiine tella than you should if you accidentally take too many tablets of lamividine
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva : other conditions linked to hepatitis b . the most serious side effects reported during therapy for hepatitis b are : side effects that have been observed during lamivuine clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , increases in liver enzymes . these may be signs of a problem with the liver and may affect the muscles . allergic reaction ( rare , may affect up to 1 in 1 , 000
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should not be used if you notice that the tablets are damaged or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivu . each film - coated tablet contains 100 mg of lamivuvine . - the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , deboss
nespo is an anti - anaemic ( means that your anaemia is not caused by any other medicine ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . your doctor may prescribe you the natural hormone erythropoietin ( ee - rith - eryth - ietin ) to help your kidneys produce more red bloodcells . your medicine contains darbepoetin alfa . chronic renal failure : symptomatic anaemia can occur when chronic renal fail is not controlled . kidney failure : your doctor will prescribe you
do not use nespo : if you have high blood pressure or are taking other medicines . if you are allergic to nespos ( darbepoetin alfa ) or r - huepo . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before using nesp : if your child has high bloodpressure or is taking medicines to treat sickle cell anaemia . if your baby has epileptic fits ( seizures ). if your newborn has convulsions ( fits ). if you suffer from seizures . if he / she has liver disease . if any of the above applies
your doctor will carry out blood tests before you are given nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemoglobulin level of 10 mg every 12 hours using the pre - filled syringe . nespos is given intravenously ( into a vein ). patients with chronic renal failure , a single injection is given under the skin into a veins ( intravenous ). your doctor may decide to inject nespol yourself . your anaemia will be monitored by your doctor . your dose of nespa will be calculated based on your body
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : very common ( may affect more than 1 in 10 people ) uncommon ( may effect up to 1 in 100 people ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon : may affect up to1 in 100 , 000 people blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare : may effect less than 1 per 10 , 000 users serious allergic reactions sudden life - threatening allergic reactions ( anaphyl
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep nespos in the original package in order to protect from light . before you start using nespen , your syringe may be stored at room temperature ( up to 30 ) for a maximum period of 7 days . do this at the end of this 7 - day period . do away with nespa after this
what nespo contains the active substance is darbepoetin alfa . each ml of solution contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the active substances darbasepoetein ala are produced by recombinant dna technology . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e487 ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack nespi is
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used for thetreatment of macul degeneration . in this disease , vision loss occurs due to damage to a part of the retina called the macula ( the coloured part of your eye ). macula is the thin layer between the retina and the macular . this makes the maculine work harder to leak fluid causing the maculas to bulge , distorting or destroying central vision . vision loss is caused
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you may have an infection or bleeding in theeye , stop using macug injection and contact your doctor immediately . if any of these apply to you , tell your doctor straight away . if the following symptoms occur , tell the doctor straightaway : eye pain or increased discomfort worsening eye redness blurred or decreased vision increased sensitivity to light small
mugen will be given to you by a doctor or nurse who is experienced in the use of injections . your doctor or pharmacist will give you macugen as a single injection into your eye . the recommended dose is 6 to 9 ml . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). macugen will not be given in combination with antibiotic eye drops . your eyes will be treated with some local anaesthetic (umbing medicine ) to reduce any pain you may have after the injection . if you are allergic to antibiotic eyedrops , your doctor may decide to monitor your eye more
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ). the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in section 4 . if you experience any of these symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use the medicine immediately after first opening . do away with the blister . do this if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection is a single dose pack supplied in a pouch . each pack contains a pre - packed syringe ( 0
palifermin belongs to a group of medicines called escherichia coli . palifermin works by stopping the growth of epithelial cells in the mouth and digestive tract ( tissues that line the skin ). palifermine is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as an additional side effect that can occur during treatments for your blood cancer . if your bloodcancer is not treated with chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( a process in which blood cells are collected and given back to you ) it may increase the risk of
do not use kepivance : if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents kepivalance is not recommended for use in children and teenagers under 18 years of age . other medicines and kepvelance tell your doctor or pharmacist if you have recently taken or might take any other medicines . kepiverance may affect the way some other medicines work . tell your pharmacist before taking heparin if
how kepivance is given your doctor will decide on the dose you will receive . your doctor or nurse will calculate your body surface area in square meters ( m² ) and will calculate the dose of cancer treatment you will be given . the recommended dose of kepvance is 60 mg . your dose of the first dose of chemotherapy ( radiotherapy ) will be administered three days before chemotherapy ( followed by chemotherapy and radiotherapy ). the first three doses of chemotherapy will be followed by radiotherapy . the first four doses of radiotherapy will be completed 24 to 48 hours after the chemotherapy . the second dose of radi chemotherapy will continue
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and decreased levels of digestive enzymes in theblood . treatment usually lasts
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconcet accordpharma is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis or who are unable to take waste products because they have too much calcium in the bloodstream ( hypercalcaemia ). to treat parathyrot
do not take cinacalcet accordpharma : if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . your doctor will check your blood calcium levels regularly while you are taking cinocalcordpharma . warnings and precautions talk to your doctor or pharmacist before taking cicalcut accordphara : if any of these apply to you , tell your doctor before taking this medicine . seizures ( fits or convulsions ) have been reported in patients with seizures . if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma should be taken with or shortly after meals . the tablets should be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual dose of cinocalcordpharma is 30 mg once a day ( morning and evening ). cinaconalc
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures ( these may be signs that your calcium levels are too low ). hypocalcaemia ( swelling of the face , lips , mouth , tongue or throat , difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every 10 people )
what cinacalcet accordpharma contains the active substance is cinacetalc . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacealcate ( as hydrochloride ). the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcordpharma looks like and contents of the pack cinaciaalcut accord
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformined belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empag
do not take jentadueto : if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function . if you suffer from uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . lactic acidosis ( see section " risk of lacticacidosis "). what is ketoacidosis ? keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin or metformined , do not take this medication and take your next dose at the usual time . if this medicine does not help you to control an upset stomach , take your daily dose of 5 mg linaglptin or 2 , 000 mg metformrin hydrochloride . if your doctor thinks that the effect of jenteadueto is too strong or
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglyciemia is a very rare ( may affect up to 1 in 10 , 000 people ) but very serious side effect . jentADueto plus sulphonylurea may cause lactic acidosis ( coma ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metforma hydrochlorides . each dosing tablet contains 1 , 000 mg linagoptin and 1 , 500 mg metin hydroxychloride respectively . the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), tal
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already infected with hiv . edhurant belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants works by reducing the amount of hla - b * 5701 in the body . it is used in combination with hl medicines in adults and adolescents aged 12 months and older , who are still infected with the hla b
do not take edurant : if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital ), phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) omeprazole , esomep
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents ( 18 years of age and older ) the recommended dose of edurant is one tablet once a day . do not take more than one tablet twice a day with food . do this if your doctor tells you to . do the same with rifabutin . edurants can be taken with or without food . if you take more edurent than you should if you accidentally take too many tablets , contact your doctor . if possible , take your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . headache , nausea , difficulty falling asleep , insomnia and dizziness may occur . your doctor may change your dose or frequency of youroutine liver tests . transaminase : increase in cholesterol and / or pancreatic amylase in your blood . abnormal dreams , rash , stomach pain . depression : tiredness , vomiting , drowsiness , decreased appetite . sleep disorders : stomach discomfort , depressed mood , dry mouth 36 low white blood cell and /or platelet count , decrease in haemoglobin in your bloodstream , triglycerides , lipase and bil
what edurant contains the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet of edurants contains rrilpivira hydrochlorine equivalent to 25 mg rilpelirine per tablet . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . film - coating : lactate monohydrate and hypromellose 2910 ( e464 ). tablet coating
avandamet tablets are taken together with two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type 2abetes either don ' t make enough insulin or their body does not make enough of a insulin to control their blood sugar levels . rosigllitazONE and met formin work together by helping the insulin work better . this helps your body to increase the blood sugar it produces . avandamnet is also used as a sulphonylurea ( a type of diabetes medicine ) in adults and adolescents .
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . how to treat your diabetes your doctor will tell you what to do if you have any of the following conditions : avandamet should not be used : if you think you may be allergic ( hypersensitive ) to rosiglitazone , metformin or any of those other ingredients of avandamanet ( listed in section 6 ) if you had a heart attack or severe angina if you suffer from heart failure if you know you
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg rosiglitazone ( 1000 mg ) metformin twice a day . this dose is achieved gradually over 1 to 8 weeks . the maximum dose is 4 mg rosciglitrazone ( 600 mg ) once a day , with metformatin . thisdose is achieved slowly over 1 or 8 weeks , but your doctor may increase your dose to the maximum dosage of 4 mg once a daily . rosigelitazONE ( 1000mg )
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and contact your doctor straightaway . lactic acidosis ( build up of lacticacid in the blood ( lactic acidsosis is a common side effect of metformin in patients with severe kidney disease ). symptoms of lact acidosis include rapid breathing , cold stomach pain
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon ( 500 mg ) metforman . each 2 mg tablet contains rosigelitazona ( 500mg ) met formin . each 3 mg tablet contain 2 mg roSiglitizone ( 1000 mg ) meetformin and each 4 mg tablet containing rosigautron ( 1000mg ) meet formin and the other ingredients are sodium starch glycollate , hypromellose , microcrystall
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidiogrelmylan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( a condition which can lead to atherotromb
do not take clopidogrel mylan 31 if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you, or if any other reason applies to your situation , talk to your doctor or pharmacist before taking clopridogrelmylan . warnings and precautions talk to you doctor or nurse before taking any
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopipidogl ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopideogrel Mylan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogl
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ), which may be fatal if used during a medical procedure to stop bleeding . it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not use doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks that you may have blood clots in your veins or arteries . warnings and precautions talk to your doctor or pharmacist before using doptelelet : if you have a history of blood clotting ( for example , if you had cancer before ), if you take the contraceptive birth control pill or hormone replacement therapy . - if recently had surgery or if you were injured . 23 if you weigh less than 23 kg . if you suffer from
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate your dose based on your body weight and will base the dose you need during your procedure . the usual starting dose is 5 mg once a day . your dose may be increased to 8 mg once daily depending on your response to doptelet . your daily dose of dopteLET may be adjusted to 20 mg , 40 mg , 60 mg or 5 mg per day depending on the severity of your platelet counts . your physician will tell you how many tablets of this medicine to take each day
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatrogboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate . tablet coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by blocking the heart arteries , thus increasing heart rate and helping to relax the muscles of the heart . rapiscan is used for a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using a machine to measure the muscles in the heart using a readmill . a scan is usually taken to measure a small amount of radiopharma ( radioactivity ) in the body . it is given into a vein by your hand . images are
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or if you are using a pacemaker . if you experience chest pain ( unstable angina ) during treatment , you should tell your doctor . if your doctor has prescribed low blood pressure ( hypotension ) or heart failure . if if you think you may be allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before using rapiscen if any of these apply to you . if any other reason applies to you , tell your
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 minutes . your doctor will adjust the dose to 10 ml depending on your weight . your dose will be adjusted by your doctor . your first dose will also be given as an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( injection ) over the course of 5 hours . the dose may
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and usually disappear after the rapiscin injection has been given 30 minutes or after any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be signs of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . if you have any of these , tell your physician immediately . if any of
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . if you have previously taken any of these medicines ( e . g . angina pectoris or " chest pain "), tell your doctor . - if the medicines you are using are nitric oxide donors such as amyl nitrite , which may lead to an increased risk of a dangerous drop in yourblood pressure . - when you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . you should take viagra once a day . viagra film - coated tablets are for oral use . viag orodispersible tablets are also for oral . swallow the tablets whole with a glass of water . do not crush or chew the tablets . viaga can be taken with or without food . take viaga at about the same time each day . it is important that you continue to take viagagra until you get an erection . if you become sexually stimulated
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below have been reported with viagra . the most serious side effects reported with the use of viagra are : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . chest pains may occur if you are in a semi - sitting position . you may need to take nitrates to relieve your chest pain . prolonged and sometimes painful erections ( may occur up to one in 1 , 000 people
what viagra contains the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are engraved with the company logo
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa . treat the symptom of moderate to severe primary restless legs syndrome in adults and adolescents .
do not take sifrol : if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sifol . if you have or have had any medical conditions or symptoms , including kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( abnormal , uncontrolled movements of the limbs ). if you suffer from advanced parkinson ' s disease , you may be given levodopa to reduce dyskineia . if any of these apply to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , the usual starting dose is 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg per day ). your doctor may increase your dose to 1 tablet sifol 0 . 010 mg ( 1 . 264 mmol per day ) if your symptoms return but do not stop taking tablets until your doctor tells you to . the usual maintenance dose is one tablet of 1 tablet each
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common : might affect up to 1 in 100 people uncommon : may effect up to1 in 1 , 000 people rare : may affects up to one in 10 , 000 patients not known : frequency cannot be estimated from the available data - parkinson ' s disease the following side effects have been reported : - dyskinesia ( abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) - urge to behave in
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , corresponding to 0 . 7 mg pramipxole as dihydrochloride monohydrate . each tablets contains 0 , 125 mg , 1 mg pramanipexol as di hydrochlorides , 0 , 25 mg , and 0 . 5 mg , respectively . the other ingredients are : 1 mg brisbane hydrochloride dihydrotide monohydrates , mannitol , maize starch , anhydrous colloidal silica ,
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to prevent allergic conditions from occurring in the eye , and to reduce the allergic reaction . allergic conjjunctivis may occur when exposure to some materials ( allergens ) or to other allergens . allergic reactions may include itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . do not try to cover up any of the effects you may have . if any of them happen , tell the doctor immediately , as you may feel worse .
do not use emadine : if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told by your doctor that you are more than 3 years old and are likely to be exposed to benzalkonium chloride ( see section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using emadade ). your doctor will decide if you should be treated with emadadine . children and adolescents do not give this medicine to children under the age of 3 years because there is no experience with the use of benzalkonsium
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is 3 drops in each eye . use this tip only once a day . do not use this remedy in both eyes . do this twice a day , at about the same time each day . 3 . 1 drop in each affected eye each day , for example , at the same place each day ( morning and evening ). 2 . 1 ml in each treated eye each time , for at least 1 hour . do the same with the emadine bottle
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects are usually mild to moderate and will usually disappear after a few days or weeks . if the drops do not work well enough , tell your doctor . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects in ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains the active substance is emadastine 0 . 5 mg / ml . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . each bottle contains one bottle .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levevetirateam is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the head ( partial onset seizure with or without secondary generalisation ). levestiracetams has
do not take levetiracetam actavis : if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetiraacetamactavis : - if you have kidney problems . - if there is any slow down in the growth or unexpected puberty development of your child . - in the treatment of anti - epileptics , levetiralacetam actsavis may increase the risk of having thoughts of harming or killing themselves . tell your doctor if you or your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis should be taken once a day , in the morning and in the evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet of 1 , 000 mg once a week ( monotherapy ) the usual starting dose is 3 , 000mg once a month . your doctor may increase your dose to one tablet once a year ( monoclonal dose ) once a daily ( monotherapies ) for 2 weeks . this will be increased to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience weakness , feel light - headed or dizzy or have difficulty breathing . these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face with an extended rash . a high temperature and increased levels of liver enzymes seen in blood tests ( a type of white blood cell ) 56 ( eosinophilia ) and enlarged lymph
what levetiracetam actavis contains the active substance is levetviracetam . levetiraacetamactavis 250 mg : each film - coated tablet contains 250 mg of levetmiracetam ( as levetvetir acetam activ ). levetiroacetam actingavis 500 mg : one film - coating tablet contains 500 mg of the active ingredient levetirusacetam , as levevetiracam actv 750 mg : two film - coat tablets contain 750 mg of of leveiracetamine ( as besilate ). leveriracetaman actavis 1 , 000 mg
incruse ellipta contains the active substance umeclidinium bromide which belongs to a class of bronchodilators . incruseipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become blocked . this makes breathing difficulties difficult . incrase ellipte helps to control the tightening of these muscles in your airways . this medicine prevents tightening of the muscles in the lungs , making it easier for air to get in and out of the lungs . it also helps to reduce your breathing difficulties
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using incrusey ellipta : if you have asthma . incruche ellipta may not be suitable for you if you suffer from asthma . if you smoke . if your doctor has told you that you have heart problems . if any of these apply to you , tell your doctor . if there is an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use incruse ellipta every day . if you use more incruce ellipta than you should if you have used more inculse ellipte than you need , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may need
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are rare ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination these may be signs of a urinary tract infection . common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead these may indicate inflammation of the sinuses
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the tray has been opened , the seal should be replaced . do away with the inhalER and do not store above 30 . do this after the
what incruse ellipta contains the active substance is umeclidinium bromide . each delivered dose contains 55 micrograms umecylidinia ( equivalent to 65 microgram ) umelidinIUM bromides . the other ingredients are lactose monohydrate ( see section 2 under ' incrusemella contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrusea ellipta is an inhalation powder . the ellipta inhaler is supplied in a grey plastic body with a light green mouthpiece cover and a
what nucala is nucal contains the active substance mepolizumab , which is a monoclonal antibody . this is a type of protein that recognises and attaches to a specific target in the body . what nucalan is used for nucale is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type white blood cell that helps the lungs to open ) and eosinaophilic asthma . how nucalo works in asthma nucaly helps to control asthma attacks by stopping the production of medicines called
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : if your child has worsening asthma 58 if your newborn has asthma - related side effects , your newborn may not be able to control their asthma properly with nucal . if your infant has severe allergic reactions to other parts of the body ( see section 4 possible side effects ). if your baby has a similar reaction to nucalan , your doctor may decide to reduce the dose . parasitic infections nuc
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a week . the recommended starting dose is 1 mg once daily . you may inject nucala yourself or in a clinic or a clinic . your doctor or nurse will show you how to inject yourself . you can use the pre - filled pen with or without food . how much nucal to use your doctor will decide how many injections you need . if you use more nucalo than you should if you have used more nuala than you have been told to ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms may be severe . symptoms may include chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( this may be due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the following reactions seen with n
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator ( 3 8 ). discard the pre filled pen if it has not been used within 7 days . do throw away any medicines via wastewater or household
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepoluzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucalo is supplied as a 1 ml clear glass ampoules in a pack containing 1 ampouled glass ampule or as a multipack containing 3 ampou
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ix azomib works by stopping cell survival and slowing down the growth of myelomas cells . it works by blocking a lot of proteins called proteasomes . what it does with ninlao what it can do for you if you have multiple myelo ? ninlalo is used in adults to treat multiple myoeloma in combination with len
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions , please tell your doctor . if any are not listed in this leaflet , please ask your doctor to explain them to you before taking this medicine . if the following apply to your child , please inform your doctor before taking the tablet . if your child is not sure , talk to the doctor or nurse before taking it . if
you will be given ninlaro by a doctor who is experienced in the treatment of multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of ninlar is lenalidomide ( a medicine that contains dexamethasone ), an anti - inflammatory medicine . the dose of each dose of the ninlara combination of lenalidomeide and dexamthasone is given as follows : 4 - week course of treatment : one dose of lenlaro once a day on the same day of the week
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy all over the body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps ( sweet '
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store below 30 . store the capsule in the original package in order to protect from moisture . do this medicine only if you notice any damage or signs of tampering to the pack . do away with the capsule after this period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule contains 2 . 3 mg ixasomib citrate . each hard capsule contains 3 . 3mg ixizomibcitrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell is gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide red ( e 172 ). what ninlar looks like and contents of the pack the capsule is white to off -
do not use palforzia : if you are allergic to peanuts ( arachis hypogaea ) or any of the other ingredients of palforbzia ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using palfourzia . children and adolescents children and teenagers from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palfiorzia does not cause allergic reactions . palfORzia is not indicated for the treatment of food allergies . if you have any further questions on the
do not take palforzia : if you are allergic to peanut or soya if you have severe asthma if your asthma is getting worse or if you had a problem swallowing . if you suffer from long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . if this happens , it may be life - long and may require treatment . if any of the above applies to you , tell your doctor before taking your palferzia . warnings and precautions talk to your doctor or pharmacist before taking palfourzia if any or any of these apply
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and allergy if you have experienced allergic reactions ( anaphylaxis ) to palforzia , your doctor may decide to reduce your dose to a single dose every 3 weeks . duration of treatment your doctor will prescribe palfourzia as initial doseescalation . these treatment steps are given as follows : the initial dose elevation and up - dosing steps are shown below . if you take more palforbzia than you should if you accidentally take too many tablets , contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions : if you have any of the following symptoms while taking palforfzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing , speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palfORzia may cause problems with the stomach and digestive system ( eosinoph
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfofas . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforbzia 100 mg oral powder in capsules with opening microcrycrystallose cellulose ( e460 ), colloidal Anhydroussilica and and magnesium strearatepalforza 300 mg oralpowder in sachet microcrystine celluloses ( e463 ), colloid anhydrated silica , and magnesium sp
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions that help to control sleeping problems . zerene is used for the treatment of adults who have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes you to feel very weak , tired muscles , severe breathing or chest problems ) if any of these apply to you , tell your doctor . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . other medicines and zere
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , take the capsule with you . if your doctor tells you to take a lower dose , you should take the capsules at the same time each day . if the dose is too low , you may need to take the dose at a different time each week . if this happens , you will need to wait until your next dose . if a dose is higher than the recommended starting dose
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare rare : not known ( affects fewer than 1 to ten users in 1000 ). very rarely : very rarely ( affects up to 1 user per
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : tablet core : microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . tablet coating : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( t171 ). printing ink : gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphates ( e133 ), silicon dioxide , ( s - 13050 ). printing
